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ABSTRACT 
 
Ion channels are important molecular targets for the treatment of human diseases. They 
are responsible for the transport of ions (e.g. potassium and calcium) through cellular 
membranes. Calcium entry through voltage-gated calcium channels (CaV) initiates electrical 
impulses, sensory processes, muscle contraction, secretion of hormones and neurotransmitters, 
and other key cellular functions. Some specific organic compounds (drugs) can inhibit the ion 
flow, which consequently affects the cellular metabolism.  Defective ion channels result in a 
variety of human diseases such as cardiovascular disease, night blindness and familial 
hemiplegic migraine, which are termed channelopathies.   
Theoretical methods are used to obtain the detailed information about the structure and 
function of ion channels and the association complexes of ligands with the channels. Homology 
modeling based on the related potassium and sodium channel structures is used to create models 
for the diverse states of the channels. Subsequent docking studies allow the investigation of the 
interaction of drugs with the internal pore of the channels. Molecular Dynamics simulations and 
Molecular Docking procedures are methods which give insight into the molecular basis of the 
biological activities. Development of the model and subsequent refinement based on the 
theoretical considerations and mutation data resulted not only in a better understanding of the 
action mechanisms of ion channels but furthermore increases our knowledge about the voltage 
dependent opening and closing mechanism and allow a more detailed investigation of drug 
interaction mechanisms.  
This thesis focuses on the mechanism and the structure of Cav1.2 calcium channel of closed 
and open pore region conformation. The Cav1.2 calcium channel belongs to the superfamily of 
voltage gated ion channels where crystal structures are not available. The closed model has been 
built based on the crystal structure of KcsA, MlotiK, Nak and a model of the bacterial sodium 
channel NaChBac. The structure of the open conformation was taken from Stary et al, 2009. At 
almost the end of the thesis in June 2011, a new voltage-gated sodium channel which shares the 
same highly conserved FxxxTxExW motif with calcium channel was published. Then, the 
newest homology model of Cav1.2 was built based on the new voltage-gated sodium channel 
crystal structure. Molecular docking of verapamil, its derivatives and qDiltiazem to the Cav1.2 
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open conformation using several Molecular Docking program packages (e.g. Glide and MOE) 
was performed to compare the best fitting results and to investigate the interaction of drugs with 
the internal pore of the channels. The results show that all drugs share similar results where the 
ligands are located in the same region between IIIS6 and IVS6 and the positively charged 
nitrogen atom of all ligands binds between the glutamic acids E1145 and E1446. The best fitting 
of verapamil, D619, T13 and qDiltiazem in Cav1.2 open conformation was used to perform MD 
simulations.  
A small variation in lipid composition can influence protein activity such as fluidity and 
lipid packing. Cholesterol is one of the main lipid components of the plasma membrane in 
mammalian cells, and is known to influence many ion channels. Here, we focus on how 
cholesterol interacts with Cav1.2 channels in open and closed conformation, applying molecular 
dynamics simulations. We used different lipid compositions, pure POPC and mixture 
POPC/CHOL bilayers to obtain information and to provide a first hint about the possible effects 
by which cholesterol influences Cav1.2 channels. 
A mechanistic understanding of the molecular and structural details of ion channels in 
general and about the underlying principles of channelopathies raises hopes of improving and 
developing better targeted drugs in the future.  
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CHAPTER 1 
INTRODUCTION 
 
1.1. Cellular Membranes 
Living cells are surrounded by membranes, which allow the cells to form units separated 
from the environment. These biological membranes are therefore important parts of the human 
cell and essential components of a living cell organization. They act as barriers and separate the 
organelles in interior of all cells (likes cytoplasm) from the surrounding outside of the cell. The 
basic unit of most biological membrane consists of phospholipid bilayers. An important function 
of the cellular membrane or plasma membrane is not only the separation of the cell but also to 
regulate the communication of the cell and the transport of various molecules as a selectively 
permeable membrane. Selected molecules or ions only are allowed to move through the 
membrane in a controlled way and also in both directions, in and out of a cell. Cellular 
membranes also play a crucial role in a variety of cellular processes, for example ion 
conductivity and cell signaling. The movement of molecules passing through the membrane can 
be either a passive or an active process. There are many mechanisms that allow the exchange of 
molecules in and out the cell as mentioned below. 
 
The passive process: This movement occurs without input of cellular energy.  
 
1. Diffusion. Some small molecules or ions are able to cross the cell membrane by 
diffusion. 
2. Osmosis. The cell membrane behaves as a semipermeable barrier. If on both sides of 
the membrane different concentrations of solutes exist, then, the solvent molecules 
may move through the membrane into a region of higher solute concentration which 
leads to an equalization of the solute concentration at both sides. 
The active process: This mechanism requires energy for transportation.  
1. Mediated Transport. The movement of a solute such as sugar across a membrane 
occurs with the help of special proteins called transport proteins.  
 2 
 
2. Endocytosis.  It is a process where the cell absorbs the molecules from outside by 
engulfing and fusing.  
3. Exocytosis. A process which releases the cellular substances contained in vesicles. 
The substances can pass into the cell by formation of a vesicle membrane with plasma 
membrane. After that, the substances release to the exterior of the cell. 
Very important for the communication of the cell via the cellular membrane are 
membrane proteins. 
1.2. Membrane proteins 
Approximately 30% of the entire proteins are membrane proteins. Membrane proteins 
can be categorized into peripheral and integral membranes. Integral membrane proteins are 
permanently attached to the membrane (e.g. G-protein-coupled receptors and ion channel). 
Peripheral membrane proteins are temporary attached either to the lipid bilayer or the integral 
membrane by a combination of electrostatic or van der Waals interactions with the lipid head 
group (e.g Phospholipase C and Lipoxygenases). Membrane proteins are important in all cells. 
They play roles in all cellular processes and mediate a wide variety of important processes such 
as transport of nutrients, export of toxins and cell-cell interactions. Now a day, the majority of 
the drugs are targeted to membrane proteins [1, 2]. Due to the limited technology to express 
membrane proteins, the structure and function of membrane proteins are still not well 
understood. Righ now there are 969 proteins in the protein database [3]. High quality crystal 
structures of membrane protein are required to extend the knowledge in this area. At the 
moment, there are new techniques applied to successfully crystallize a variety of membrane 
proteins the bicelle [4] and HILIDE [5] methods are introduced to obtain structure of membrane 
proteins Generally, there is continuous development to improve these methods. 
They are key drug targets 
1.3 Ion channels  
Ion channels are pore-forming proteins and their function is to facilitate the diffusion of 
ions across the cellular membrane. Channels are usually ion selective. Ions are able to pass 
through in highly selective way the channel and they prevent the passage of others. Under 
physiology conditions, calcium channels allow only calcium ions to go through. [6]. The 
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pathway of selected ion flow through the channel by electrochemical gradients accounts for an 
ion's concentration gradient across a cell membrane. Channels are major components of the 
nervous system which play key roles in variety of biological processes such as cardiac, skeletal 
and smooth muscle contraction. Therefore, channels have been intensively studied and they are 
important molecular targets for the treatment of many human diseases. 
There are now many techniques which have been applied to study the ion channels such 
as voltage clamp electrophysiology, immunohistochemistry, reverse transcriptase-polymerase 
chain reaction analysis (RT-PCR) and also large variety of computational methods. 
 
1.4 Classification of the ion channels 
There are several possible ways to classify ion channels into groups. For instance,  
(1) By gating: The conformational change between closed, open and inactivated of the 
channels is called gating.  
(a) Voltage-gated ion channels are controlled by the voltage gradient across the 
membrane. (e.g. voltage-gated calcium channels, voltage-gated potassium channels 
and voltage-gated sodium channels etc.).  
(b) Ligand-gated ion channels. These channels are regulated by conformation changes 
induced by ligands. (e.g. nicotinic acetylcholine receptor (nAchR) and 
neurotransmitter gamma-aminobutyric acid receptor (GABA) etc.) 
(2) By ion. Channels can be categorized by the species of ions passing through those gates.  
(e.g. chloride channel, sodium channel, potassium channel etc.) 
 
1.5 Voltage-gated calcium channels (Cav ) 
Cav s  play a major role to control calcium influx and respond to change in intracellular 
calcium concentrations that occur in such cellular system as cardiac muscle, neurotransmitter 
release and muscle contraction [7]. 
Crystal structures of the transmembrane domains of Cavs are not available. Therefore, the 
homology modeling method was used to build Cav structure models based on voltage-gated K+ 
and Na+ channels (Kv and Nav). Even though, Kv and α1 subunits of Cav are composed of four 
basic domains, each domain formed six transmembrane but there are still significant differences 
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at the atomic level. The Kv channel contains four identical repeats while Cav is non-identical 
formed by a single polypeptide [8]. Molecular dynamics simulations and experimental data are 
used to support that the four domain repeats of Cav are arrangement in a clockwise manner [9]. 
Another difference between Kv and Cav are the P segments, especially selectivity filter region. 
For Kv, the main carbonyl oxygen atoms in the selectivity filter orient towards the lumen [10]. In 
case of Cav, the side-chains of four glutamates are predicted to face the pore [11-14].   
 
 
(a) 
 
(b) 
Fig 1.1 (a) Schematic cartoon of voltage-gated calcium channel (b) The α1 subunit is comprised 
of four homologous domains, each of which contains six transmembrane helices. 
 
The global architecture of Cavs is composed of four basic components. α1 subunit is 
located in the cell membrane and calcium ions can pass through.  The auxiliary β, CaM and α2δ 
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subunits bind with high affinity to the loops of domain I and II. Cav α2δ is a single pass 
transmembrane subunit which is formed by two disulfide-linked proteins [15, 16]. Fig 1.1a 
shows also the transmembrane Cav which consists of four homologous repeats membrane-
spanning domains (I–IV). Each repeat is formed by six segments (S1-S6) shown in Fig 1.1b. 
The first 4 segments (S1-S4) are the voltage-segment domain and the last 2 segments (S5-
S6) form the calcium-selective pore domain. The S4 segment contains positively charged 
residues and acts as a voltage sensors controlling Cav gating.  
 
1.6 Classification of voltage-gated calcium channels  
 
 
Fig 1.2 The percent identity of all voltage-gated calcium channels α1 subunits. 
 
The Cavs can be divided into low-voltage-actived (LVA) and high-voltage-actived 
(HVA) calcium channels depending on the depolarization necessary to activate the channel [17].  
HVA calcium channels are activated at the membrane rapidly and at more negative potentials 
than LVA. HVA channels are all members of Cav 1 and Cav 2 family. All members of the Cav 1 
family (Cav 1.1-1.4) are of the L-type, Cav 2.1 is of the P/Q type, Cav 2.2 is of the N-type and Cav 
2.3 is of the R-type. Furthermore, all members of the Cav 3 family (Cav 3.1-3.3) are in the HVA 
classification which is named T-type [18]. The amount of the similarity of the amino acid for 
everal of voltage-gated calcium channel is given in Fig 1.2.   
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Table 1. Sizes of individual α1 subunits of voltage-gated calcium channels 
 
Subunit / origin Molecular 
weight 
(kDa) 
Number 
of amino 
acids 
Reference 
Cav1.1 / rabbit skeletal muscle 
Cav1.2 / rabbit heart 
Cav1.2 / rabbit lung 
Cav1.2 / rat aorta 
Cav1.3 / human pancreas 
Cav1.3 / human brain 
Cav1.4 / human retina 
Cav1.4 / human retina 
 
212 
242.8 
242.5 
243.6 
247.6 
245.2 
 
219.5 
1873 
2171 
2166 
2169 
2181 
2161 
1912 
1966 
Tanabe et al. 1987 [19] 
Mikami et al. 1989 [20] 
Biel et al. 1990 [21] 
Koch et al. 1990 [22] 
Seino et al. 1992 [23] 
Williams et al. 1992a [24] 
Bech-Hansen et al. 1998 [25] 
Strom et al. 1998 [26] 
 
Cav2.1 / rabbit brain 
 
Cav2.2 / ray 
Cav2.2 / human brain 
 
Cav2.3 / ray 
Cav2.3 / rat brain 
 
257.3 
273.2 
264.5 
262.5 
251.8 
251.8 
252 
2273 
2424 
2326 
2339 
2237 
2223 
2222 
 
Mori et al. 1991 [27] 
Horne et al. 1993 [28] 
 
Williams et al. 1992b [29] 
Horne et al. 1993 [28] 
Soong et al. 1993 [30] 
 
Cav3.1 / mouse brain 
Cav3.2 / human heart 
Cav3.3 / rat brain 
 
 
205.2 
2295 
2387 
1835 
Klugbauer et al. 1999a [31] 
Cribbs et al. 1998 [32] 
Lee et al. 1999a [33] 
 
 
The length of the protein chain of almost all calcium channels ranges approximately from 
1870 to 2420 amino acids. A summary over all calcium channels together with the number of 
amino acid of the α1 subunit and the related molecular weight  is given in Table 1 [34]. As can 
be deduced from Fig 1.2, the similarity of LVA and HVA channels is less than 30 % of sequence 
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homology.  Two subfamilies of HVA channels: L-type (Cav 1) and Neuronal types (Cav 2) have 
about 50% sequence homology. Individual members of each subfamilies share more than 80% of 
sequence homology. 
 
1.7 Mechanism of voltage-gated calcium channels 
 
 
 
 
Fig 1.3 Activation and inactivation of voltage-gated calcium channel. 
 
 
The voltage-gated calcium channels are opened and closed by voltage of calcium ion 
changes as shown in Fig 1.3.  At resting closed state, the voltage-gated calcium channel is closed 
and ions cannot pass. Then, the membrane potential will be increased, which results that the 
channel can be activated to open state upon depolarization and allows ions to pass. During the 
depolarization, the open probability of the channel is remained briefly and then voltage-
dependently reduced by channel inactivation leading to inactivated closed state. Instead, 
inactivated closed state cannot immediately be reactivated. It requires a brief period of time to 
repolarization of the membrane and recovery from inactivation.  On the other hand, the 
membrane potential at the open state also can deactivate the channel leading to the resting closed 
state [35]. 
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1.8 Voltage-gated calcium channels molecular pharmacology 
 The activity of voltage-gated calcium channels is essential to couple electrical signals on 
the cell surface to physiological events in cells. The pharmacology of the each family of calcium 
channels is individual e.g. the molecular targets of Cav1.2 channels are used widely in the 
therapy of cardiovascular diseases (Table 2). For more detail, the summarization of molecular, 
physiological, and pharmacological properties of all calcium channel family are reviewed by 
Catterall et al (2005) [8]. Detailed properties of L-type Cav 1.2 calcium channels are given in 
Table 2. 
 
Table 2. Molecular properties of the L-type calcium channel Cav 1.2. 
 
Channel name Cav1.2 
Description voltage-gated calcium channel 1 subunits 
Other names 1c, cardiac or smooth muscle L-type Ca2+ channel, cardiac 
or smooth muscle dihydropyridine receptor 
Molecular information human: 2221aa, Q13936 (cardiac), L04569 (cardiac) chr. 
12p13.3, CACNA1C  
rat: 2169aa, P22002 (cardiac) M59786 
mouse : 2139aa, Q01815 (cardiac), L01776 (cardiac)  
Associated subunits 2, ,   
Functional assays Patch clamp (whole cell, single channel),calcium imaging, 
cardiac or smooth muscle contraction hormone secretion. 
Current ICa,L 
Conductance Ba2+ (25pS) > Sr2+ = Ca2+ (9pS)3
Ion selectivity Ca2+ > Sr2+> Ba2 >> Mg2+ from permeability ratios 
Activation Va= 4mV (in 15 mM Ba2+) to 17mV (in 2mM Ca2+); a = 
1ms at +10mV 
Inactivation Vh = 50 to 60mV (in 2mM Ca2+),18 to 28mV (in 
1015mM Ba2+); 
fast = 150ms, slow = 1100ms (at Vmax in 15 mM Ba2+) 
Activators BayK8644, dihydropyridine agonists, FPL64176  
Gating inhibitors dihydropyridine antagonists (e.g. isradipine, IC50 = 7nM at 
60mV; nimodipine, IC50  = 139nM at 80mV) 
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Blockers selective: devapamil (IC50 = 50nM in 10mM Ba2+ at 60mV) 
and other phenylalkylamines; diltiazem (IC50 = 33M in 10 
mM Ba2+ at 60mV and 0.05Hz); non-selective: Cd2+ 
Radioligands (+)-[3H-isradipine(Kd<0.1nM) and other dihydropyridines; 
() - H-devapamil, (Kd = 2.5nM), (+)-cis-H-diltiazem  
( Kd  = 50nM) 
Channel distribution cardiac muscle, smooth muscle (including blood vessels, 
intestine, lung, uterus); endocrine cells (including pancreatic 
-cells, pituitary); neurons  
subcellular localisation: concentrated on granule containing 
side of pancreatic -cells; on neurons preferentially located 
on proximal dendrites and cell bodies. 
Physiological functions excitation-contraction coupling in cardiac or smooth muscle, 
action potential propagation in sonoatrial and 
atrioventricular node, synaptic plasticity, hormone secretion.
Mutations and pathophysiology required for normal embryonic development (mouse, 
zebrafish) 
Pharmacological significance mediates cardiovascular effects of clinically used Ca2+ 
antagonists 
Comments Tissue-specific splice variants exist; in addition to cardiac 
channels, smooth muscle (2169aa) and brain (2140-2144aa) 
channels have been cloned. The gene for Cav1.2 was first 
isolated and characterised in rabbit (2171aa,P15381, 
X15539) 
 
 
1.9 L-type calcium channels  
 The four members of L-type calcium channels have specialized functions in skeletal 
muscle and cardiac muscle, and they are, therefore, therapeutic targets for cardiovascular disease 
treatment. The conformation changes of gating states (resting, open and inactivated) L-type 
calcium channels are accompanied by changes in drug binding affinity upon the change in 
membrane voltage (activation/depolarization). L-type calcium channels are sensitive to three 
major classes of drugs [34, 36] : dihydropyridines (DHPs) [37-39], phenylalkylamines (PAAs) 
[40-42], and benzothiazepines (BZPs) [43]. From experimental approaches [8, 34-43], it is 
known that these three classes of drugs bind to separate but overlapping regions in IIIS5, IIIS6, 
and IVS6 segments of the α1 subunits. The binding residues of these drugs are shown in Fig 1.4. 
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Fig 1.4 The amino acid residue interaction with dihydropyridines (DHPs), 
phenylalkylamines (PAAs), and benzothiazepines (BZPs). 
 
As can be seen from the Fig 1.4 different drugs interact at different binding sites, leading 
there to different interaction mechanisms which have been investigated in more detail. However, 
there are still questions open which conformations (open or closed) are interacting with the drug. 
The intention of the present work is to focus on voltage gated L-type calcium channels 
Cav1.2 and to investigate the mechanism and the structure of closed and open pore region.  
 
1.10 Calcium channel blocker - Phenylalkylamines (PAAs) 
Phenylalkylamines (PAAs) such as verapamil, gallopamil or devapamil, belong to the 
class of calcium channel blockers of L-type [44]. The common structure of PAAs is the presence 
of two methoxylated aromatic rings. In this work, the structure-activity relationships of PAAs 
focus on varapamil and its derivative. Verapamil is a drug of this class within currently clinical 
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use in particular for the therapy of coronary heart disease. The qualitative and quantitative 
structure-activity relationship of various groups of verapamil was investigated based on an 
analysis of the frequency dependent negative inotropic action exerted in cat papillary muscles. 
The inotropic effect of verapamil which relate to muscular contractions is mainly caused by the S 
conformation [45]. The verapamil shows effects on the slow Ca2+ current and movement which 
affects cardiac excitation-contraction coupling. The quantitative results was obtained by 
comparing ED50 values [46].  
The PAA verapamil and its derivatives can be divided into of 3 groups. Group A 
concerns derivatives differently substituted at the benzene ring near the asymmetric carbon atom 
(Fig 1.5). In Group B the isopropyl group is exchanged (Fig 1.6). The last group C contains 
derivatives with different substitutents at the amino group nitrogen atom (Fig 1.7). 
 
 
               R =                           Molecular name 
3,4-(OCH3)2               Verapamil 
\             3,4,5-(OCH3)3   D600 
4-OCH3           D557 
3,4-Cl2             D595 
3-CF3                    T13 
3-OCH3-4-OH               PR23 
3,4-CH3               D559 
 
Fig 1.5 Group A: Derivatives differently substituted at the benzene ring near the asymmetric 
carbon atom. 
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       R’ =              Molecular name 
   C6H5CH2-  D490 
   n-C8H17-  D586 
   CH3CH2-          D525 
 
Fig 1.6 Group B: Exchange of isopropyl group by other substituent. 
 
 
 
R1 =  R2 =  R3 =         Molecular name 
Isopropyl- homoveratryl- H-  D594 
H-  CH3-  H-  PR22 
CH3-  CH3-  H-  D619 
CH3-  homoveratryl- CH3-  H1 
 
Fig 1.7 Group C: Derivatives with different substituent at the amino group nitrogen atom. 
 
 In summary, for substituents of group A and B it was found that the character of the 
substituent strongly affects the potency of various compounds, but it is not affected by the 
inotropic effect.  The tertiary amino nitrogen of group C and two benzene rings of group A are 
important for frequency dependent negative inotropic. Moreover, the molecular importance of 
the N-methyl group C is based on steric effects.  
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2.1 Lipid interaction of the channel.  
The interaction of membrane lipids with integral membrane proteins is important and 
influences the membrane protein structure and function. However, the mechanisms between lipid 
composition and membranes are not well understood yet. The next part of the introduction gives 
an overview of various lipid compositions and how they modulate the membrane protein.  
 
2.2 Lipid composition 
The cell membrane or plasma membrane is a selectively permeable lipid bilayer. It 
separates the cytoplasm (intracellular fluid) from the extracellular moiety. It contains a variety of 
biological molecules such as phospholipids, glycolipids and cholesterol. Phospholipids are the 
most abundant compound in the cell membrane.  The Mammalian cell membrane basically 
consists of thin layers of phospholipids which are arranged in such a way that the polar head 
groups point toward the intra- and extra- cellular areas. The phospholipids have a hydrophilic 
head which are exposed to water and two hydrophobic tails at the center of bilayer. Moreover, 
cholesterol is located inside the membrane (Fig 1.8) [47]. The cell membrane contains 
approximately 30-50 mol % of cholesterol.   
 
 
Fig 1.8 The primarily lipid bilayer consists of phospholipids and cholesterol. 
 
The effects of lipid composition on the membrane protein and subsequent activity are 
very complex. Evidently, the molecular composition of lipids strongly affects the protein 
structure and function. Up to now, the molecular mechanisms of protein-lipid coupling are still 
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poorly understood. The changes of lipid characteristics, for example head group type, the length 
of the tail, additional presence of cholesterol are factors which modulate the protein functions. In 
case of ion channels, the molecular mechanisms of protein-lipid interactions can influence 
directly and indirectly the protein function [48] which may occur in different ways 
1. Alteration of the protein structure and function. The membrane proteins folding are 
dictated by their primary structure and their environment. The residues in the interior 
membrane protein are less hydrophobic than the residues in contact with the tail of lipid 
bilayer. The hydrophobic and hydrophilic properties of the bilayer play a crucial role for 
protein folding and activity. However, not all domains of the channels are in contact with 
the bilayer, particularly the extracellular domains, mostly non-helical, which are located 
outside the membrane [49]. 
2. Alteration of membrane fluidity. The fluidity is a measurement of the packing efficiency 
of the lipid. The movement of a tightly packed membrane is more difficult than the 
movement in more fluid environment. Thus, membrane fluidity is affecting the dynamics 
of the membrane protein as observed in the nAchR studies [50].  
3. Alteration of bilayer thickness. Normally, the hydrophobic region of transmembrane 
(TM) domains interacts with the acyl chain of bilayer while polar, aromatic and charged 
residues are in contact with the interface region on each side of bilayer. The short 
hydrophobic TM are usually expelled from the membrane, due to the fact that it is 
unfavorable for hydrophobic region of the TM and bilayer hydrophobic thickness to be 
mismatched. Furthermore, for the long hydrophobic TM in contact with the acyl chain of 
bilayer will tend to tilt to match with the membrane thickness. Then, this rearrangement 
may affect the protein function [51-53]. 
 
Lipid rafts are specialized regions that are enriched of cholesterol in membrane 
microdomains (Fig 1.9). These membrane regions influence the membrane fluidity, they are 
more tightly packed and form higher ordered ensembles than the surrounding bilayer.  
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Fig 1.9 Lipid raft structure 
2.3 Cholesterol effect 
 Cholesterol plays a crucial role in regulating the properties of membranes. As already 
mentioned it regulates the fluidity of the membrane and modulates the function of membrane 
protein [54]. In case of ion channels, it has been described that numerous ion channels are 
affected in different way by cholesterol. For example, the suppression of channel activity is 
affected by an increase in membrane cholesterol. This effect happens in several types of K+ 
channel, voltage-gated Ca+2 and Na+ channels etc. In contrast, there are several types of ion 
channels, such as transient receptor potential (Trp) channel which are inhibited by cholesterol 
depletion. Moreover, in some case changing in membrane cholesterol affects the biophysical 
properties such as the voltage dependence of active or inactive channels [55]. The mechanisms 
for cholesterol modulates of ion channel are not well understood. The regulation of ion channels 
by cholesterol have been proposed that cholesterol might interact directly or via indirectly with 
ion channel. Three different mechanisms of channel regulation have been suggested [56, 57]  
1. Specific interactions of cholesterol with the channel protein. 
2. Changes of the physical properties of the membrane bilayer (i.e. fluidity). 
3. Importance of cholesterol for maintaining the scaffolds for protein-protein interactions     
    (“lipid-rafts”). 
 
. 
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CHAPTER 2 
METHOD AND PROCEDURE  
 
The access to experimental structural data of membrane proteins like G-protein coupled 
receptors (GPCRs) or ion channels by X-ray crystallography or NMR spectroscopy is still 
limited. For X-ray crystallography of these proteins it is rather difficult to obtain crystals, as the 
structure is dependent on the surrounding, the membrane. Separation of the proteins from the 
membrane can lead to irreversible structural changes, which inhibit ordered crystallization. 
Limitations for NMR spectroscopy are the size of the systems, as NMR-spectroscopy can be 
applied only to smaller protein systems.  
Up to now, no transmembrane domains of calcium channels were crystallized. Many 
techniques such as patch clamp, fluorescence resonance energy transfer (FRET) used lead to 
significant new insights about the structure, function and drug interaction with the channels. 
Computational methods are also additional useful method to investigate these research areas. In 
general, the protein structure prediction using computational methods can be divided into three 
approaches  
1) Homology modeling 
2) Threading or fold recognition 
3) Ab Initio.  
For this work, homology modeling using multiple templates and modeling the loops 
using an Ab Initio method were applied. Homology modeling based on the crystal structure of 
potassium and sodium channels are used to create models for the diverse states of the voltage-
gated calcium channel Cav1.2.  Besides the model of L-type calcium channel Cav1.2, the T-type 
calcium channel Cav3.1 was investigated. Due to the lack of conserved residues at the loop 
region, the Ab Initio method was applied to predict the loop structure of calcium channel Cav 3.1 
combined with the results of experimental investigations. 
Subsequently, molecular docking studies were used to investigate ligands interacting with 
the internal pore of the Cav1.2 channel in the open state. Molecular dynamics simulations (MD) 
are important methods which give insight into the molecular basis of the biological activities. In 
this work, MD was also used to stabilize the model structures. Further, the MD of ligands with 
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Cav1.2 channel was investigated for better understanding of the action mechanism and to 
increase knowledge about drug interaction mechanisms. 
 
2.1 Homology modeling 
For unknown protein structures such as membrane proteins, homology modeling was 
introduced to construct the three-dimensional structure of a known atomic-resolution model of 
the protein (target) and related homologous protein (template). The procedure consists of three 
steps [58].   
 
The first step: To select similar proteins (known 3D structures) as templates and to align between 
the target (unknown structure) and one or more templates: 
The success of this method relies on the sequence alignment between target and suitable 
templates. In this work, sequence searches from Expasy [59] database using BLAST [60] were 
performed to identify related sequences. The quality of the models depends on the sequence 
identity of the sequence alignment. Unfortunately, voltage-gated calcium channel shares in 
general low sequence identity with K+ channel crystal structure templates. Thus, it is necessary 
to find possible homologs for a protein by comparing several sequences. In this work, the 
multiply sequence alignment was built from ClustalX [61] program combined with manual 
intervention based on sequence conservation information.   
 
The second step: To build the model:   
 To construct the 3D model of Cav1.2 closed conformation, the software package 
MODELLER [62] was used to generate the model from the alignment of a sequence. This 
program builds a structure with an extended strand for target and fold by satisfaction of spatial 
restraints [63] from the alignment of the target and its templates. The hydrogen bonding features 
and main chain dihedral angles are preserved from the template structure.  The model was 
manually adjusted according to the side-chains to optimize hydrophobic contacts, salt bridges, 
hydrogen bond formation and aromatic – aromatic interactions.  
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The third step: To evaluate the quality of the model: 
It is important to check the model structure using the quality assessment tools. There are 
various quality assessment programs available to evaluate for correctness of the overall fold, 
errors over localized regions and stereochemical properties of the model e.g. Prosa2003 [64], 
Verify 3D [65], WHAT_CHECK [66], Procheck [67]. A simple preliminary check can also 
obtain by a Ramachandran plot.  
The entire process of homology modeling may be necessary to repeat until a satisfactory 
model is obtained. In this work, molecular dynamic simulation of the satisfactory model in lipid 
bilayer environment is also used to evaluate the quality and to stabilize the model. 
 
2.2 Ab Initio method. 
 Another approach for 3D structure prediction is the Ab Initio method. This method 
predicts the native state of a protein structure from the sequence information only. In general, Ab 
Initio methods consist of 3 steps:  
1) Try to retrieve template proteins of similar folds from the database. In case that no 
appropriate template is identified in the database, the structure will be build by Ab Initio 
modeling.  
2). Define the energy function compatible with the predicted structure.  
3). Apply efficient and reliable algorithms to search the global predicted structure. The 
structure prediction ultimately is done through physical forces acting on all-atom of the model.  
This method requires long computing time. Thus, we introduced the Ab Initio method to 
predict the loop structures of calcium channel Cav 3.1 using ROSETTA [68] program and I-
Tasser server [69]. The ROSETTA method is a distributed-computing implementation based on 
Rosetta algorithm which tested, developed and succeed on globular proteins in Critical 
Assessment of Techniques for Protein Structure Prediction (CASP) [70]. For I-Tasser, the 
method is based on threading fragment structure reassembly [71].  
 
2.3 Model Evaluation. 
To evaluate the homology models, quality assessment method are necessary to check the 
quality of the constructed models. The quality check should be able to verify the reliability of the 
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model. It should be able to distinguish between properly versus improperly folded models, and 
evaluate steric and geometric properties of the models. There are numerous quality assessment 
programs which different criteria methods available. Most of the methods have been developed 
using empirical data from globular proteins of known structure. In our work, the models quality 
was assessed using Prosa2003, Verify3D, WHAT_CHECK Packing, Procheck, ProQresLG and 
ProQres MaxSub.   Prosa2003 [64] is a program to check the potential error in 3D models of 
protein structures. It uses statistical potential of distance and surface-dependent statistical for Cα 
atoms to obtain the model. Verify3D [65] is the method that analyzes the 3D atomic model with 
its own amino acid sequence 1D. It will provide with a statistical potentials from real proteins. 
WHAT_CHECK Packing [66] checks all possible atom types in all possible positions around the 
fixed fragments. Procheck [67] addresses the stereochemical parameter of a protein. The 
structure is classified into highly populated to forbidden regions by the Ramachandran plot. It 
shows the Φ/ψ torsion angles for all residues in the structure. ProQres [72]  analyzes contact 
between atom-atom, residue-residue, solvent-accessible surfaces and secondary structure.  
 
2.4. Molecular Docking [73]. 
Molecular docking is a method which gives insight into the molecular basis of the 
biological activities for better understanding of the action mechanism and increased knowledge 
about drug interaction mechanisms. 
 A basic component of every docking program is a search algorithm and an energy scoring 
function which can be based on 
 
1. Force fields: molecular mechanics force fields for the estimation of binding affinity.  
2. Empirical data: functions fitted to experimental data which based on the knowledge of 
known protein-ligand interaction. 
3. Knowledge-based methods: capture the knowledge of receptor-ligand binding by 
statistical data alone. 
 
The general docking procedure generates docked models by finding the binding region on 
macromolecules (proteins) where the ligand most likely interacts. Then, the results of docking 
for groups of ligands are clustered based on the location and examining energetic or ranking 
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score. Additionally, the experimental data are important in determining the probable binding 
sites. Then, the best models and experimental data should be compared to filter results. We can 
perform refinement docking where the ligand is restricted to a specified region based on these 
filtered results. 
 
2.4.1 Docking programs used in thesis 
 Glide (Grid-based Ligand Docking with Energetics) [74]  and MOE [75], which have a 
different approach are the docking programs used in this work.  Glide program places ligands in 
the receptor by grid docking alignment. This program computes the grid in terms of position, 
orientation and conformation space available. Each ligand atom is matched with the grid point 
with the lowest energy within its neighborhood. The scoring function is reported in term of 
GlideScore (Fig. 2.1).  
 
GlideScore (GScore) is given by 
 
GScore = a * vdW + b * Coul + Lipo + Hbond + Metal + Rewards + RotB + Site 
 
Where  
     vdW      =  van der Waals interaction energy. 
     Coul      =  Coulomb interaction energy. 
     Lipo      =  Lipophilic-contact plus phobic-attractive term. 
     HBond    =  Hydrogen-bonding term. 
     Metal     =  Metal-binding term. 
Rewards  =  Various reward or penalty terms. 
     RotB     =  Penalty for freezing rotatable bonds. 
     Site      =  Polar interactions in the active site. 
     a,b   =  the contribution from the Coulomb term is capped at -4 kcal/mol  
a= 0.050, b = 0.150 for Glide 5.0.  
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Fig 2.1. The standard docking protocol of GLIDE docking program. 
 
The aim of MOE docking program is to search a favorable binding between ligand and 
receptor. Docking application in MOE program consists of several steps (Fig 2.2).  Each ligand 
poses can be used to rescore and to refine poses. Additionally, the knowledge of pharmacophore 
was introduced to constrain the poses. 
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Fig 2.2. The work flow of the docking application of the programm MOE 
 
2.4.2 Docking methodology 
From experiment it is known that ligands preferably to block the open conformation. 
Thus, the molecular docking of this work was focused on the open conformation (structure from 
Stary et al, 2009) of the ion-gated calcium channel and the improved open conformation with 
various ligands.  
 
Ligand preparation:  
Coordinates of ligands were generated with GaussView [76] and the geometry optimized 
with the Hartree-Fock method using 3-21G basis set implemented in Gaussian03 [77].  
 
Glide Docking program: 
Protein Preparation Wizard workflow implemented in Maestro 8.5 was used to prepare 
the protein using default settings. Both protein and ligands were parameterized with the OPLS 
force field. The Receptor Grid Generation panel performed the grid map generation of the 
receptor. The grid was generated overall binding residues known the experimentally. Docking 
Conformation 
analysis 
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calculations preformed in Standard Precision (SP) mode using the Ligand Docking panel. The 
Receptor Grid Generation and Ligand Docking panels are functions in the Glide module.  
 
MOE Docking program: 
The standard protocol of the procedure in MOE 2008 was applied in this work. The 
Alpha Triangle placement which derives poses by random superposition of ligand atom triplets 
alpha sphere dummies in the receptor site is to determine the poses. The London dG scoring 
function estimates the free energy of binding of the ligand from a given pose. The functional 
form is a sum of terms: 
 
  
  atomibondsh ligm MMHBHBfllex
PicG fCfCE  
Where 
 c  =  the average gain/loss of rotational and translational motion. 
 Eflex  = the energy due to loss of flexibility of the ligand. 
CHB  = an hydrogen bond energy  
fHB  = measures geometric imperfections of hydrogen bonds  
CM  =  a metal ligation energy 
fM  = measures geometric imperfections of metal ligations  
Di  =  the desolvation energy of each atom i 
 
2.5. Molecular dynamic simulations 
Molecular Dynamic Simulation (MD) is a theoretical and computational method based on 
solving the Newton’s equation of motion. This method is used to mimic the behavior of the 
system as a function of time. MD provides a basis for a more complete understanding of 
biological systems and aids in the interpretation of experiments concerned with their properties.  
In a molecular dynamics simulation, the trajectory of the molecules and atoms for 
choosing the potential function  1,..., NU r r  of the position of the nuclei represent the potential 
energy of the system when the atoms are arranged in specific configuration. The potential energy 
is usually constructed from the relative positions of the atoms with respect to each other. Forces 
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are derived as the gradients of the potential with respect to atomic displacement as shown in 
below formula.  
 
 
This form implies the presence of a conservation law of the total energy , 
where is the instantaneous kinetic energy. 
 
 
 
Fig 2.3. Cartesian coordinated laboratory-fixed reference frame used to define a position vector. 
 
The translational motion of spherical molecules is caused by a force exerted by some 
external agent. The motion and the applied force are explicitly interpreted by Newtonian. 
Newton’s equation of motion of a  particle system is written in a set of  coupled second 
order differential equation in time. The functional form is a sum of terms: 
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O
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where is the mass of the molecule,  is a vector that locates the atoms with respect to a set of 
coordinate axes as shown in Fig 2.3 [78] 
The force fields describe atomic interactions with contributions from bonded (bond 
length, bond angle and bond torsion) and non-bonded (van der Waals and electrostatic) 
interactions. Several force fields have been developed such as AMBER [79], GROMOS [80], 
CHARMM [81] and OPLS [82].  
 
2.5.1 Molecular Dynamics simulation studies of the open conformation of Cav1.2 calcium  
channel with Verapamil, D619, T13 and qDitiazem 
 The simulation setup of all ligands with open Cav1.2 is the same procedure as following. 
Molecular dynamics simulations have been carried out for the open conformation of Cav1.2 
embedded in DOPC [83] lipid bilayer. These simulations were performed with the Gromacs 
software version 4.0.4 using the Amber-03 force-field. The topology of ligands was generated 
with antechamber [84]. The ligand charges were taken from the quantum chemical calculation 
(Gaussian 03) with the Hartree-Fock 3-21G basis set. The TIP3P water and 4 Ca2+ ions were 
placed along the z-axis.  Cl- ions were added randomly within the solvent to neutralize the 
system. Snapshots of the trajectory were written out every 20 ps.  The system was energy 
minimized with the steepest descent algorithm, followed by positional restrained MD for 2 ns. 
Subsequently, 40 ns of unrestrained MD simulation were carried out using the NVT ensemble.  
The V-rescale thermostat and Parrinello-Rahman barostat algorithms were used. Electrostatic 
interactions were calculated explicitly at a distance smaller than 1 nm, and long-range 
electrostatic interactions were calculated at every step by particle-mesh Ewald summation. 
Lennard-Jones interactions were calculated with a cut-off of 1 nm. All bonds were constrained 
by using the LINCS algorithm, allowing for an integration time step of 2 fs. The simulation 
temperature was kept constant by weakly (τ = 0.1 ps) coupling the lipids, protein, and solvent 
(water + counter ions) separately to a temperature bath of 300 K. The pressure was kept constant 
by weakly coupling the system to a pressure bath of 1 bar with semi-isotropic pressure coupling. 
More details of parameter files are shown in Appendix I.  
 
 
m ir
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2.5.2 Molecular Dynamics simulation studied of closed and open conformation Cav1.2 
calcium channel in pure POPC and content of cholesterol in the membrane  
Molecular dynamics simulations of Cav1.2 in a closed and an open conformation have 
been carried out in pure POPC and POPC/CHOL environment. The system was set up by the 
following steps:  
 
 
Fig 2.4.  The setup of the molecular dynamics simulation of Cav1.2 channel in pure POPC. 
 
1. Generate the topology file of Cav1.2 of closed and improved conformation obtained 
from homology modeling.  
2. For POPC environment (Fig 2.4), replicate the starting configuration of a 128-lipid 
POPC bilayer in X and Y axis to create of a bilayer of 512 lipids. For POPC/CHOL 
environment (Fig 2.5), generate the mixture lipid bilayer POPC and 25% cholesterol 
from single POPC and cholesterol molecules. Randomly add cholesterol into the 
POPC bilayer.  
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3. Superimpose the Cav1.2 channel with POPC and POPC/CHOL bilayer and use 
INFLATEGRO tool to expand the POPC for POPC system. In case of the 
POPC/CHOL system, a minimal number of overlapping POPC and CHOL molecules 
was removed.   
4. Slowly compress only the POPC using the INGLATEGRO tool and POPC/CHOL 
using the tool included in Gromacs. Locate the channel in the center of bilayer and 
minimize the whole system. Repeat the compress and minimize whole system step 
until the area per lipid of POPC is around 65 Å2. 
5. Insert the 5 Ca2+ along the pore. 
6. Solvate water TIP3P, add NaCl. Neutralize system by adding Na+ ion.  
 
 
 
Fig 2.5.  The setup of the molecular dynamics simulation of Cav1.2 channel in POPC/CHOL. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
 
3.1 Sequence conservation of L-type calcium channel 
 The sequence between Cav1.2 from Oryctolagus Cuniculus rabbit (accession number: 
P15381) and other L-type calcium channels as performed to investigate the structure, functional 
and evaluation relationship of L-type calcium channels. All available sequences were 
downloaded from Expasy [85] and Blast database (Table 3.1).  
 
Table 3.1 Species available of each isoforms of L-type calcium channel from Expasy and Blast  
database. The available sequences from Expasy and Blast database are highlighted in    
grey.  
 
Species Cav1.1 Cav1.2 Cav1.3 Cav1.4
Oc = Rabbit = Oryctolagus Cuniculus      
Hs = Homo sapiens     
Ms = Mouse = Mus musculus      
Rn = Rat = Rattus Norvegicus      
Gg = Chicken = Gallus gallus      
Cf = Dog = Canis lupus     
Rc=Bull frog=Rana catesbeiana     
Md= opossum = Monodelphis domestica     
Cp=Chimpanzee=Pan troglodytes     
Ma=MESAU=Mesocricetus auratus      
Bt=Bovien=Bos taurus      
ONCMY=Oncorhynchus mykiss      
Mm = Monkey = Macaca mulatta     
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 Fig 3.1. Multiple sequence alignment of the IVS6 of Cav1.2. 
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The multiple sequence alignment was constructed on all found of L-type channels to 
obtain the similarity among them. This family shares 80 % sequence identity. The multiple 
alignment of domains I to IV shown in Appendix II point out that the L45, S5, P-helix and S6 of 
every domain are conserved.  All binding residues are located along IIIS5, IIIP, IIIS6, IVP and 
IVS6 [34]  and are shown to be highly conserved. Our work focus on all binding residues of 
DHPs, PAAs and BTZs drug on L-type channel which are pointed by green circle. In Fig 3.1 
only the IVS6 part is shown. For all binding residues see Appendix III. 
 
3.2 Sequence alignment of Cav1.2 closed conformation 
  
                                                 L4-5                                         S5                                          
 
Cav1.2I  VPSLQVVLNSIIKAMVPLLHIALLVLFVIIIYAIIGLELFMGKMHKT 
Cav1.2II  WNSLSNLVASLLNSLRSIASLLLLLFLFIIIFSLLGMQLFGGKFNFD 
Cav1.2III  AKGLKHVVQCVFVAIRTIGNIVIVTTLLQFMFACIGVQLFKGKLYTC 
Cav1.2IV  GEGIRTLLWTFIKSFQALPYVALLIVMLFFIYAVIGMQVFGKIALND 
KcsA   LVKLLLGRHGSALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQ 
Mlotik  STFFPVLGRVLANEARNLIGVTTLFGVVLFAVALAAYVIERDIQPEK  
NaK                 TLKRMLRACLRAWKDKEFQVLFVLTILTLISGTIFYSTVEG 
NachBac  VPSLRRLVDALLMTIPALGNILILMSIFFYIFAVIGTMLFASVAPE 
NavAb            VPQMRKIVSALISVIPGMLSVIALMTLFFYIRAIMATQLF   
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                                                                                                                P 
 
Cav1.2I  GPKHGITNFDNFAFAMLTVFQCITMEGWTDVLYW 
Cav1.2II                EMQTRRSTFDNFPQSLLTVFQILTGEDWNSVMYD  
Cav1.2III  SWENSKFDFDNVLAAMMALFTVSTFEGWPELLYR 
Cav1.2IV  TEINRNNNFQTFPQAVLLLFRCATGEAWQDIMLA 
KcsA             TYPRALWWSVETATTVGYGDLYP 
Mlotik            SIPQAMWWAVVTLSTTGYGDTIP 
NaK     PIDALYFSVVTLTTVGDGNFSPQ 
NachBac         YFGNLQLSLLTLFQVVTLESWASGVMR 
NavAb          WFGTLGESFYTLFQVMTLESWSMGIVR 
         
                                                                                                         S6  
   
Cav1.2I    QDAMGYELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSK 
Cav1.2II  GPSFPGMLVCIYFIILFISGNYILLNLFLAIAVDNLA 
Cav1.2III  PIYNYRVEISIFFIIYIIIIAFFMMNIFVGFVIVTFQE 
Cav1.2IV  ETPCGSSFAVFYFISFYMLCAFLIINLFVAVIMDNFDY 
KcsA       VTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQERRGH 
Mlotik      QSFAGRVLAGAVMMSGIGIFGLWAGILATGFYQEVRR 
NaK   DFGKIFTILYIFIGIGLVFGFIHKLAVNVQLPSILSN 
NachBac  PIFAEVPWSWLYFVSFVLIGTFIIFNLFIGVIVNNVE 
NavAb   PLMEVYPYAWVFFIPFIFVVTFVMINLVVAIIVDAMA 
 
Fig 3.2. Multiple sequence alignment of the pore region of Cav1.2 closed conformation. 
 
The alignment of the pore region of Cav1.2 closed channel based on multiple sequence 
alignment of potassium channel KcsA [86], Mlotik channel [87], the nonselective cation channel 
NaK [88] and homology model of the NaChBac sodium channel [89] (is shown in Fig 3.2). The 
overall sequence identity between calcium channels, potassium channels and the sodium channel 
NaK are quite low. An alignment between Cav1.2 and NaChBac are more closely related. Highly 
conserved residues are shaded black. Positions of mainly conserved changes are shaded grey. 
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3.3 Sequence alignment and inner pore domain prediction of Cav3.1 T-type calcium  
channel 
 Due to the sequences similarity, the sequence of L-type channel Cav1.2, P/Q-type channel 
Cav2.1 and T-type channel Cav3.1, Cav3.2 and Cav3.3 were used for alignment on the inner pore 
domains (S5-P-S6) of Cav3.1 (Fig 1 in the following publication). The homology model of this 
region was built based on homology model of Cav1.2 as template [9]. The Ab Initio methods by 
using ROSETTA program and I-Tasser server were used to construct the structure and to 
compare the results with experimental data which focus on six cysteines residues located in the 
extracellular loop between segment IS5 and the pore helix. We hypothesize that forming of the 
disulfide bonds within the loop and/or neighboring segment of the cysteines in the extracellular 
loop influences gating.  
The 10 structures obtained from ROSETTA program reveal that the position of six 
cysteine residues does not form disulfide bonds which is inconsistent with the hypothesis (Fig 
3.3). For the I-Tasser server models, only 3 models from 10 models were in agreement with the 
experimental evidence which is demonstrated in Fig 3. on supplementary material of the 
publication. Therefore, Ab Initio methods are still not accurate enough to observe the various 
possible disulfide bonds in the model. 
 
 
Model 1     Model 2 
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Model 3     Model 4 
 
  
Model 5     Model 6 
   
Model 7     Model 8 
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Model 9     Model 10 
 
Fig 3.3. 10 different models from ROSETTA programs obtained by the Ab Initio method. The 6 
cysteines are shown in purple sticks. The extracellular loop is presented in green ribbon. 
 
 
 
 
 
 
 
 
 
 
Paper 1 
 
Cysteines in the loop between IS5 and the pore helix of Cav3.1 are essential for channel 
gating. 
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Abstract The role of six cysteines of CaV3.1 in channel
gating was investigated. C241, C271, C282, C298, C313,
and C323, located in the extracellular loop between segment
IS5 and the pore helix, were each mutated to alanine; the
resultant channels were expressed and studied by patch
clamping in HEK293 cells. C298A and C313A conducted
calcium currents, while the other mutants were not functional.
C298A and C313A as well as double mutation C298/313A
significantly reduced the amplitude of the calcium currents,
shifted the activation curve in the depolarizing direction and
slowed down channel inactivation. Redox agents dithiothreitol
(DTT) and 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) shifted
the current activation curve of wild-type channels in the
hyperpolarizing direction. Activation curve for all mutated
channels was shifted in hyperpolarizing direction by DTT
while DTNB caused a depolarizing shift. Our study reveals
that the cysteines we studied have an essential role in CaV3.1
gating.We hypothesize that cysteines in the large extracellular
loop of CaV3.1 form bridges within the loop and/or
neighboring channel segments that are essential for channel
gating.
Keywords T-type calcium channels . Voltage gating .
Cysteine .Modulation .Modeling
Introduction
Low-voltage activated (LVA) calcium channels activate at
more negative membrane voltages than high-voltage activated
(HVA) channels [22]. By initiating so-called low-voltage
calcium spikes, LVA channels specifically contribute to
neuronal excitability [10]. The molecular basis of the gating
peculiarities of LVA channels is largely unknown. All
voltage-gated calcium channels are composed of four
homologous domains, each containing six transmembrane
segments S1–S6 and a pore loop (P) between segments S5
and S6. Four voltage-sensing domains each composed of the
transmembrane segments S1–S4 are arranged around a
central pore domain formed by four sets of S5-P-S6 [26]. First
insights into a differential contribution of individual domains
to channel gating were obtained by a domain swapping
approach between the LVA CaV3.1 and the HVA CaV1.2
channel. These experiments demonstrated that domains I, III,
and IV determine the midpoint for voltage-dependent
activation [19]. Similarly, swapping parts of CaV3.1 and
CaV3.3 channels pointed to a central role of domain IVand to
a lesser impact of domain I [8]. Exchange of the basic
uppermost arginines in each of the S4 segments by neutral
cysteines substantiated the importance of the IIIS4 segment
and a moderate role of the segments IS4 and IIS4 [17].
LVA calcium channels contain a unique conserved large
external domain located between the IS5 region and the
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pore loop (P). In HVA calcium channels this loop is smaller
and not well conserved. Six cysteines located within this
region (Supplementary Figure 1) are conserved among all
three CaV3 channels. Disulfide bonds between these
cysteines may stabilize the conformation of this large
extracellular region. Considering that this region is linked
to the conducting pore, it might contribute to the modulation
of the channel gating. Swapping the whole domain in the
CaV3.1 channel had a much stronger effect on channel
activation than the mutation in the voltage sensor itself [17,
19] suggesting a principal role of other structure(s) within
domain I for channel gating. A possible role of this region
for pore opening is underlined by the discovery of mutations
within the CaV3.2 sequence related to epilepsy [15]. Several
of these mutations resulted in a greater calcium current and
some cause channel openings at more hyperpolarized
potentials.
LVA channels were also found to be modulated by redox
agents [14, 18, 21, 30]. Reducing agents were shown to
interact specifically with CaV3.2 [14]. This effect was
attributed to their ability to act as metal chelators rather than
to reduction of channels’ cysteines [21]. Thiol modulating
agent lipoic acid interacts exclusively with four extracellular
cysteines in the CaV3.2 channel sequence located in the
extracellular loop between S1 and S2 segments of domain I
and in the loop connecting S5 segment to the pore loop in
domain II [18]. Traditional thiol oxidizing agent DTNB
interact with these, but also with additional not yet identified
sites.
Cysteines in the IS5-P connecting loop are on the
extracellular side of the channel and could be the site of
action of redox agents. Out of 16 extracellularly located
cysteines in the CaV3.1 sequence, 13 are located in the pore
regions of individual channel domains (Fig. 1). The length
of some of these extracellular loops suggests that inter-
domain disulfide bridges may be possible.
Here we investigated the contribution of each of the
endogenous loop cysteines to channel gating and to redox
modulation by substituting alanine for each of them in turn.
Four of these mutants (C241A, C271A, C282A, and C323A)
did not form functional channels, indicating a key role of these
residues in channel gating. C298A and C313A conducted
calcium currents, but with altered voltage dependencies of
activation and kinetics of inactivation. These findings and the
observed changes in redox regulation highlight the functional
importance of these cysteine residues.
Materials and methods
Mutagenesis The mouse brain T-type CaV3.1 calcium
channel cDNA (accession number AJ012569 [16]) was
cloned into the plasmid pEGFP N-1 (Clontech, Mountain
View, CA) after removing the stop codon, thereby creating
a CaV3.1-EGFP fusion protein. The mutations were
introduced in wild-type (WT) CaV3.1 cDNA using a
polymerase chain reaction based method. In general, PCR
reactions were performed on partial cDNA fragments
(cassettes) of CaV3.1. The mutant CaV3.1 channels were
constructed by subcloning these mutant cassettes into the
full-length CaV3.1-EGFP fusion protein. All regions
replaced by PCR fragments were sequenced and the
presence of the desired mutation(s) was confirmed.
Cell culture and transfection All experiments were carried
out on either HEK 293 cells (electrophysiological experiments)
or tsA-201 cells (confocal imaging) transiently transfected by
pEGFP N-1 plasmids containing either cDNA of wild-type or
mutant CaV3.1 subunits. Cells were grown in MEM with
Eagle’s salts, containing 10% fetal calf serum, 100 U/ml
penicillin–streptomycin in an atmosphere of 5% CO2, and
95% air at 37°C. Cells were harvested from their culture
flasks by trypsinization and plated out onto 13-mm round
glass coverslips (Slavus, Bratislava, Slovakia) coated with
0.01% poly-L-lysine. The cells were transiently transfected
with the expression vector using LipofectAMINE 2000
according to the instructions of the manufacturer (Invitrogen,
Carlsbad, CA). Cells were incubated for 2 to 3 days following
transfection before electrophysiological experiments.
Confocal microscopy The confocal images were obtained
∼30 h after transfection. The data illustrated are representative
for 10–15 tsA-201 cells from three independent experiments.
For confocal microscopy CaV1.3 were expressed in tsA-201
cells. CaV1.3 displayed similar kinetics in tsA-201 and HEK
293 cells. Confocal images were acquired with a Zeiss
LSM-510 confocal laser scanning microscope, using a ×63
(1.4 NA) oil immersion objective. The plasma membrane
was stained with 1 μM FM4-64 (amphiphilic styryl dye,
Molecular Probes). Images were acquired using an argon laser
(excitation, 488 nm; emission BP505–530 nm emission filter)
for the EGFP-tagged CaV3.1 α1-subunits and a He–Ne laser
(excitation, 543 nm; emission filter, LP650 nm) for FM4-64.
Homology modeling The IS5 helix, the extracellular loop
(EC loop I), and the IP segments of the L-type calcium
channel CaV1.2 (accession number: P15381), the T-type
channels CaV3.1 (accession number: Q9WUT2), CaV3.2
(accession number: O95180), CaV3.3 (accession number:
Q9P0X4), and the P/Q-type calcium channel CaV2.1
(accession number: P97445) were aligned using ClustalX
[13]. Additionally, the sequence of the KV1.2 crystal
structure (pdb identifier: 2r9r) [20] was aligned with the
CaV sequences, as suggested previously [24]. Supplemental
Figure 1 shows the alignment of the full pore domain (S1–S6)
of CaV3.1, CaV3.2, and NaChBac with that of KV1.2.
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The structure model of CaV3.1 was generated with
Modeller9v6 [6]. Ten ab initio models of the extracellular
loop connecting IS5 and IP were constructed using the
I-Tasser server [33].
The inner pore domain (S5-P-S6) of CaV3.1 is based on
the CaV1.2 homology model. The validated homology
model of CaV1.2 was used as template, because it shares
high sequence similarity with CaV3.1 in these regions. The
voltage-sensing domains (S1–S4) are based on the Kv1.2
crystal structure (pdb: 2r9r, 3lut) [11, 20]. The accuracy of
ab initio models is given by the TM-score [35], which
measures the correctness of the global topology of such
models. The value for our best loop model is 0.46, which is
slightly below the >0.5 threshold for correct topology
models, but clearly above the ≤0.17 threshold indicating
random prediction [34]. Therefore this model can be used
to assess, if and which cysteines from other domains might
be close enough for direct interactions within this loop.
Electrophysiology and data analysis The Ca2+ current
through expressed WT and mutated channels was studied
using the conventional whole cell configuration of the
patch-clamp technique using the HEKA-10 patch-clamp
amplifier (HEKA Electronic, Lambrecht, Germany). The
Fig. 1 Schematic structure and
alignment of the extracellular
loop of CaV α1 subunits in
domain I. a shows the loop
connecting the IS5 segment and
the putative pore helix. The loop
region is enlarged in the inset.
Each amino acid is represented
by one open circle. Filled circles
indicate the location of six
cysteine residues in this loop.
The approximate positions of
other extracellularly located
cysteines are indicated by
arrows. Barrels represent
putative α-helices in the
channel structure. b illustrates
an alignment of CaV1.2
(accession number: P15381),
CaV3.1 (accession number:
O43497), CaV3.2 (accession
number: O95180), CaV3.3
(accession number: Q9P0X4),
CaV2.1 (accession number:
P97445), and KV1.2 (pdb
identifier: 2r9r). Identical
residues in all five CaV channels
are shaded dark gray; residues
that are identical in four CaV
channels are shaded light gray.
Highly conserved cysteines
in EC loop I are bold and
underlined, whereas cysteines
conserved only in the T-type
family are shown in bold
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extracellular solution contained (in mM): NaCl, 155; CaCl2, 2;
MgCl2, 1; CsCl, 5; HEPES, 10; pH 7.4 (NaOH). The
intracellular solution contained (in mM): CsCl, 130; EGTA,
10; MgCl2, 5; TEA-Cl, 10; Na2-ATP, 5; and HEPES,
10; pH 7.4 (CsOH). The osmolarity of the internal solution
was approximately 300 mOsm; the osmolarity of the external
solution was adjusted by adding glucose to a final value
2–3 mOsm lower than the internal solution. Extracellular
solutions were exchanged by a gravity-driven flow system
with manually controlled valves. Patch pipettes were manu-
factured from borosilicate glass (Sutter Instrument, Novato,
CA) with input resistance ranging from 1.6–2.0 MΩ. The cell
capacitance had an average value of 15.5±0.4 pF (n=202).
Average series resistance was 4.11±0.07 MΩ (n=202). Series
resistance was compensated for up to 70%. The bath was
grounded using an AgCl pellet connected to the experimental
chamber through an agar bridge.
Data were recorded with HEKA Pulse 8.5 and analyzed
offline using HEKAPulsefit 8.5 and Origin 7.5 software. Data
were sampled at 10 kHz and filtered at 3 kHz. Capacity
transient and series resistance were compensated by built-in
procedures of the EPC 10 amplifier. Residual linear leak
current was subtracted by a built-in procedure of the EPC 10
amplifier. Only cells with a holding current smaller than 10%
of peak current amplitude were used for experiments.
The holding potential (HP) in all experiments was −100mV.
Current–voltage (I/V) relationships were measured by stepping
every 3 s from a HP to membrane potentials between −90
and +80 mV for 50 ms. Steady-state inactivation was
measured by series of 5-s long prepulses to voltages between
−150 and −10 mV, followed by a 5 ms return to a HP and a
40 ms test pulse to −30 mV.
Conductance was calculated according to the equation:
GðV Þ ¼ IðV Þ
V  Vrev ð1Þ
where G(V) is the conductance at test potential V, I(V) is
amplitude of the current measured at test potential V, V is
the membrane voltage, and Vrev is the reversal potential.
Voltage dependence of current activation was satisfactorily
fitted by the Boltzmann equation:
GðV Þ
Gmax
¼ 1
1þ e
ðVV0:5actÞ
dVact
ð2Þ
where Gmax is a maximal conductance, V0.5act is a half-
maximal activation voltage, dVact is a slope factor of
activation curve, and other symbols have the same meaning
as in previous equation. Steady-state inactivation curves
were fitted by a Boltzmann equation in the form:
IðV Þ
Imax
¼ 1
1þ e
VV0:5inact
dVinact
ð3Þ
where Imax is the maximal current amplitude, V0.5inact is the
voltage at which the current is half-inactivated, and dVinact is
the slope factor of the steady-state inactivation curves. To
evaluate time constants of current activation and inactivation,
individual current traces were fitted by the Hodgkin–Huxley
equation, using the m2h kinetics [17, 27].
The voltage dependence of τinact was fitted by a function:
tðV Þ ¼ e VVtð Þst þt 1ð Þ ð4Þ
where Vτ is the voltage at which τ is equal to 1+ τ(∞), sτ
represents the voltage sensitivity of inactivation, and τ(∞) is
the asymptotic value at positive potentials.
Data are given as mean ± SEM from n cells. Statistical
significance between two groups was determined by
unpaired Student’s t test and considered significant when
p<0.05.
Drugs and reagents All drugs and chemicals were obtained
from Sigma-Aldrich, St. Louis, MO, except where noted
otherwise. Solutions of dithiothreitol (DTT) and 5,5′-dithiobis
(2-nitrobenzoic acid) (DTNB) were prepared fresh prior to the
experiment directly in the bath solution.
Results
Cysteine substitutions C241A, C271A, C282A, and C323A
result in non-functional channels
Six cysteines located in the loop connecting the IS5 segment
and the IP pore helix of the CaV3.1 channel (Fig. 1) were
individually mutated to alanines. Further, the double-mutant
C298/313A was constructed. C241A, C271A, C282A, and
C323A resulted in non-functional channels when transiently
expressed in HEK 293 cells, while mutants C298A and
C313A conducted calcium channel currents (Fig. 2). To
investigate whether the lack of current observed for mutants
C241A, C271A, C282A, and C323A resulted from impaired
plasma membrane targeting, we examined the subcellular
distribution of EGFP-fused channel proteins by confocal
microscopy. The localization of the channel proteins was
visualized using the membrane-selective dye FM4-64
(Supplementary Figure 2). Similar overlap between green
fluorescence of EGFP-fused channel proteins and red
fluorescence of FM4-64 dye in functional and non-
functional constructs suggests no differences in their membrane
localization (exemplified in Supplementary Figure 2). These
findings demonstrate that the lack of current observed for
C241A, C271A, C282A, and C323Amutants is unlikely to be
caused by a failure in membrane targeting of the mutant
EGFP-fused CaV3.1 α1-subunits.
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Fig. 2 Comparison of activation and inactivation of WT and mutant
channels. Examples of current traces measured during a current–
voltage protocol from the WT, C298A, C313A, and C298/313A
channels are demonstrated in (a). Corresponding I/V relationships for
inward current amplitudes are shown in (b). Solid lines are spline
connectors of experimental data points. I/V relationships from (b) were
transformed into conductance–voltage relations using Eq. 1 in (c).
Solid lines represent fits of experimental data by Eq. 2. Examples of
current traces measured during a steady-state inactivation protocol
from WT, C298A, C313A, and C298/313A channels are demonstrated
in (d). Corresponding SSI relations are shown in (e). Solid lines
represent fits of experimental data by Eq. 3
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Cysteines C298 and C313 contribute to the voltage
dependence of channel gating
A comparison of the voltage dependencies of activation and
inactivation of WT channel, C298 and C313A channel
mutants and C298/313A double-mutant channel is shown
in Fig. 2. Examples of current traces are shown in Fig. 2a.
Both single mutations as well as the double mutation
reduced the current amplitude approximately fivefold
(Fig. 2b), significantly shifted the voltage dependence of
current activation in the depolarizing direction and signif-
icantly increased the slope factor of the activation curve
(Fig. 2c, Table 2). However, the activation slope factor was
not affected by the double mutation.
Examples of current traces measured from all three
channels by a steady-state inactivation protocol are shown
in Fig. 2d. The mutations did not affect the midpoint
voltage of the inactivation curves (−69.4±0.7 mV, n=7;
−71.0±1.2 mV, n=10; −70.0±0.7 mV n=11; and −69.0±
0.9 mV, n=7 for the WT, C298A, C313A, and C298/313A
channels, respectively; Fig. 1e). The effects of both
mutations on the slope factors of the voltage dependence
of inactivation were less prominent than the effects on
activation (3.6±0.4, 4.1±0.2, 4.9±0.2, and 4.3±0.4 mV for
the WT, C298A, C313A, and C298/313A channels,
respectively) and only for C313A statistically significant
(p<0.05).
Functional cysteine mutants have altered channel kinetics
Next we investigated the kinetics of channel gating of the
functional cysteine mutants. Activation and inactivation
kinetics were determined by fitting the current recordings
obtained with I/V protocol (Fig. 2a) by the Hodgkin–Huxley
equation in the m2h form [17, 27]. Both single mutations as
well as a double mutation significantly accelerated current
activation during depolarization to voltages between −40 and
0 mV (Fig. 3a and Supplementary Table 1). Inactivation was
significantly accelerated by mutation C298A and by the
double mutation C298/313A only (Fig. 3b and Supplemen-
tary Table 1).
Averaged inactivation time constants were fitted by the
Eq. 4. Both mutations shifted voltage dependencies of time
constants of macroscopic inactivation to more positive
membrane voltages (Table 1). Mutation C298, but not C313
decreased the voltage sensitivity. This decrease was
preserved in double mutant C298/313A. Plot of time
constants of inactivation vs. time constants of activation
revealed a moderate correlation (R=0.94) between both
processes for the C313A mutant and the double-mutant
C298/313A (R=0.86). No correlation was observed for
mutant C298A suggesting a role of this residue in coupling
the process of activation to inactivation (Fig. 3c).
The kinetics of channel deactivation were evaluated at
repolarization voltages between −140 and −50 mV
(−60 mV for wild type and double mutant). Time constants
of channel deactivation were calculated from monoexpo-
nential fits to tail currents (Fig. 3e). While deactivation was
not affected by mutation C298A, it was statistically
significantly accelerated by C313A. In contrast, the double
mutation significantly slowed down deactivation (Fig. 3d
and Supplementary Table 2).
Redox agents DTT and DTNB modulate WT and mutant
CaV3.1 channels
It was previously shown [30] that the reducing agent
dithiothreitol and the oxidizing agent 5,5′-dithiobis(2-
nitrobenzoic acid) modulate T-type calcium channels.
DTT is a highly selective redox agent for thiol groups in
proteins. When applied to the bath solution one would
expect an interaction with cysteines exposed on the
extracellular side of CaV3.1. As shown in Fig. 4, DTT
(10 mM) moderately inhibited WT channel. DTNB in
2.5 mM concentration completely blocked the current
through the WT channel. Both mutations altered these
redox regulations. In both single mutants as well as in
double-mutant DTT slightly stimulated the calcium cur-
rent. Removal of either cysteine at positions 298 and 313
reduced inhibition by DTNB by 50% and the double
mutation further reduced this inhibition (Fig. 4 and
Table 3).
Current enhancement by DTT may be due to a shift in
the voltage dependence of current activation. Indeed, a
small increase of the calcium current amplitudes was
observed at voltages more negative than the peak of the
I/V relationship. DTT had virtually no effect at voltages
higher than the peak of the I/V relationship (Fig. 5, left
column). The corresponding activation curves are shown in
the right column of Fig. 5. Averaged V0.5 and dV values are
Table 1 Mutations altered voltage dependence of inactivation time
constants
Vτ (mV) sτ (mV) τ(∞)
WT −38.4±2.2 5.1±1.1 14.7±0.1
C298A −12.1±3.2 7.8±1.0 17.8±0.5
C313A −21.8±1.7 4.9±0.5 16.3±0.2
C298/313A −10.1±3.0 9.0±0.9 24.2±0.7
Averaged data presented in Fig. 3b were fitted by Eq. 4. Vτ represents
the voltage at which τ is equal to 1+ τ(∞), sτ is the voltage sensitivity
of activation or inactivation and τ(∞) is the asymptotic value at
positive potentials. Vτ characterizes the position of voltage depen-
dence of τinact along the voltage axis
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summarized in Table 2. All three shifts of voltage dependen-
cies of current activation were statistically significant. The
slope factors were not significantly different from control (i.e.,
in the absence of DTT). Negative shifts caused by DTT
application partly neutralized the positive shifts caused by the
mutations, most prominently in the case of the double mutant.
To illustrate both effects we have included the activation curve
of WT CaV3.1 (dashed lines, Fig. 5d, f, h).
In parallel to the DTT effect on the I–V relation
DTNB shifted the voltage dependence of current activa-
tion of the WT channel in the hyperpolarizing direction
(Fig. 6). In contrast, the shift of channels activation was in
the depolarizing direction in both single mutants and in
the double mutant (Fig. 6 and Table 3). Activation slope
factor was significantly increased in C298A mutant.
Significance of this increase was preserved in the double
mutant.
Location and putative interactions of cysteines
in a calculated model of CaV3.1
Next we generated a putative structural model of the
membrane spanning S1–S6 segments with an attached
extracellular pore loop built by ab initio methods. Out of
the 55 cysteines in the CaV3.1 channel, 16 are located on
the extracellular surface of the channel (see Fig. 1).
Domain I contains nine extracellular cysteines. Six are
located in the long extracellular loop connecting IS5 and
IP and three cysteine residues (C104, C109, and C114)
are in the voltage-sensing domain, in the loop connecting
Fig. 3 Comparison of
activation–deactivation kinetics
of the WT and mutant channels.
a and b demonstrate voltage
dependencies of activation
(a) and inactivation (b) time
constants for the WT, C298A ,
C313A, and C298/313A
channels. Time constants of
current activation were
calculated by fitting current
traces from Fig. 2a by the
Hodgkin–Huxley equation in
the m2h form. Solid lines in b
represent fits of averaged data
by Eq. 4. Inactivation time con-
stants for individual mutants are
plotted versus
activation time constants
evaluated at a test potential
of −10 mV in (c). Solid lines
are fits of the data with a
linear function with following
correlation coefficients R and
probability values P as follows:
C298A R=0.13, P<0.83;
C313A R=0.94, P<0.006;
C298/313A R=0.86 P<0.06.
The time constants of current
deactivation depicted in (d)
were obtained from monoexpo-
nential fits of current traces
shown in (e). Solid lines
represent fits by B-splines
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IS1 and IS2. These cysteines are in equivalent positions
to the lipoic acid interaction site described for Cav3.2.
Domain II contains only one accessible cysteine residue,
C889, which is also part of the lipoic acid interaction
site, as inferred from CaV3.2 studies. In domain III, two
cysteines (C1441 and C1455) are found in the loop
connecting helix IIIS5 and IIIP. Accessible cysteines in
domain IV are located in the loops connecting IVS5 and
IVP (C1770 and C1776) and the loop connecting IVP and
IVS6 (C1815 and C1821).
Extracellular located cysteines from domain III (C1441 and
C1455) as well as loop cysteines from domain IV (C1770,
C1776, C1815, and C1821) are in close proximity to EC loop I
(see Fig. 7).
Fig. 4 Interaction of
redox agents DTT and DTNB
with WT and mutant channels.
Averaged time courses of the
amplitude of inward calcium
currents measured during
40-ms long depolarizing pulses
to −30 mV are shown for the
WT CaV3.1 (a and e), C298A
mutant (b and f), C313A
mutant (c and g), and C298/
313A mutant (d and h). Left
column demonstrates effect of
10 mM DTT on inward current
amplitudes. Inhibition of current
amplitudes by 1 and 2.5 mM of
DTNB is shown in the right
column. The time of application
of each agent is indicated by
arrows
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Fig. 5 DTT shifts channel
activation in the hyperpolarizing
direction. I/V relationships
measured under control
conditions and in the presence
of 10 mM DTT are shown in
(a). In b conductance–voltage
relationships calculated from
these I/V relationships are
demonstrated. Solid lines are
Boltzmann functions (Eq. 2).
The same analysis for C298A
channels is shown in (c) and
(d). In e and f results from
experiments on C313A channels
are summarized. g and h show
experimental data measured
from double mutant C298/313A.
Dashed line in d, f, and
h represents the Boltzmann
function calculated for WT
CaV3.1 channel from the data
demonstrated in (b)
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Discussion
The extracellular loops connecting transmembrane segment
IS5 and the pore loop IP of different members of the CaV
family vary significantly in length and amino acid
composition (Fig. 1). The large loops that are characteristic
of CaV3.1–CaV3.3 contain six cysteine residues. Their
functional role in CaV3 gating is currently unknown. Four
of the six cysteines in this loop region are conserved
between LVA and HVA channels (Fig. 1) while cysteines at
positions 271 and 282 (numbering of CaV3.1) are specific
for CaV3 channels. Disulfide bonds formed between two
cysteines are considered as stabilizing elements in proteins.
We mutated these residues to alanines and analyzed the
functional effects of the mutations by patch clamping. We
provide evidence that cysteines C241, C271, C282, and
C323 are essential for proper channel function. Replacing
them by alanine resulted in non-functional channels.
Membrane localization of functional and non-functional
channel proteins was similar within resolution limits of
confocal microscopy (Supplementary Figure 2) making a
total failure of membrane trafficking caused by mutation in
IS5-IP loop unlikely. Until now only intracellular motif—
loop connecting domains I and II—was identified as
determinant of trafficking CaV3 channels [2, 23, 31].
Nevertheless, we cannot exclude partial impairment of
membrane localization of mutant channel proteins. Such
impairment could also explain a decrease of average current
densities through the mutant channels compared to the
wild-type channel.
Altered gating properties of functional mutants demon-
strate that cysteines C298 and C313 are likely to participate
in conformational changes during activation, inactivation,
and deactivation. A depolarizing shift of the activation
curve with bigger slope factors was previously reported by
Talavera and coauthors [27, 29] for aspartate-to-glutamate
changes in the EEDD pore locus of the CaV3.1 channel.
These authors hypothesized that the observed changes in
gating were caused by the change of the selectivity filter
structure [27]. Since C298 and C313 are located outside the
conducting pathway of the channel pore, the effects of their
mutation are presumably due to a different molecular
mechanism. We speculate that the IS5-P loop may
contribute to the modulation of channel gating via its link
to the pore helix and the pore forming segment IS6. The
mutation of cysteines C241, C271, C282, and C323 may
disable channel opening via a partial collapse of the
structure of the IS5-P loop and/or a rearrangement of
cysteine bridges within the loop.
Such profound structural change in tertiary structure of
channel region directly linked to the pore could affect
channel selectivity. This seems not to be the case for single
mutants as reversal potentials extrapolated from experi-
mental data in Fig. 2b resulted in similar values (22.3±0.5,
22.7±1.4, and 22.8±1.2 for WT, C298a, and C313A
channels, respectively). We cannot exclude that the double
mutation C298/313A may affect selectivity as evident from
the extrapolated average reversal potential of 25.8±1.5
(significantly different from wt, p<0.05).
Mutations of C298 and C313 slowed down activation,
inactivation, and deactivation gating. This effect was more
prominent when these cysteines were mutated simulta-
neously. Cysteines C298 and C313 probably do not interact
with each other because in this case removal of each single
cysteine should have a similar effect as removal of both of
them. Alterations of inactivation time constants correlated
with alterations of activation time constants in mutant
C313A. No correlation was observed for mutant C298A. A
correlation between activation and inactivation parameters
is observed for many but not for all mutations [28].
Todorovic and coauthors [30] demonstrated that redox
agents modulate the current through T-type calcium
channels both in vivo and in vitro. Reducing agents DTT
and L-cysteine selectively enhanced current through the
CaV3.2 channel by relieving zinc inhibition mediated by
H191 in the IS3–IS4 loop [21]. H191 is specific for the
Table 2 Voltage dependence of activation and its alteration by DTT
Channel construct Control 10 mM DTT
V0.5 (mV) dV (mV) V0.5 (mV) dV (mV)
WT −47.7±0.7 (12) 3.5±0.6 −51.3±0.5### 3.8±0.2
C298A −40.4±1.1*** (10) 6.3±0.4*** −45.3±1.3### 6.4±0.3
C313A −37.9±0.7*** (8) 5.6±0.3*** −43.5±0.9### 6.0±0.3
C298/313A −41.6±1.5** (7) 4.5±0.5 −45.5±1.6# 4.5±0.8
Voltage dependencies of activation for WT, C298A, C313A, and C298/313A channels either under control conditions or in the presence of 10 mM
DTT were fitted with Eq. 2. Resulting half-maximal voltages (V0.5) and slope factors dV are listed together with the numbers of tested cells in
brackets
***p<0.001; **p<0.01 (significantly different from the WT); ### p<0.001, # p<0.05 (significant differences between control and DTT)
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Fig. 6 DTNB causes
depolarizing shift of channel
activation in mutant channels.
a, c, d, and e show I–V relations
measured under control
conditions (open circles) and in
the presence of 2.5 mM DTNB
(filled circles). Experimental
points are connected by spline
lines. In b, d, f, and h, data from
these I–V relations are converted
into conductance–voltage
relations. Solid lines are
Boltzmann functions (Eq. 2).
First row demonstrates results
from the WT CaV3.1 channels,
the second one from the C298A
channels, third one from the
C313A channels, and the last
one from the double-mutant
channel C298/313A
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CaV3.2 channel and in a previous report [14] reducing
agents did not affect CaV3.1 and CaV3.3 channels. In
accord with this finding DTT did not enhance current
through the CaV3.1 channel, instead, it caused a minor
inhibition of the inward current. Nevertheless, DTT did
enhance current at membrane voltages below −30 mV
when C298 and/or C313 were replaced by alanine. This
enhancement was caused mostly by a hyperpolarizing shift
of current activation. Shift of activation curve towards more
negative membrane voltages caused by DTT partly
compensated the depolarizing shift of activation caused by
the mutations (Fig. 5b, d, f, and h).
Oxidizing agents like DTNB or lipoic acid inhibit the
current through all CaV3 channels [14, 18]. While the
interaction site for lipoic acid was identified [18] and
consists of three cysteine residues in the IS1–IS2 linker plus
one cysteine at the top of IIS5 segment, the interaction site
for DTNB is more complex. Here we present the first
evidence that C298 and C313 are likely to participate in the
DTNB site. Removal of each single cysteine reduced
current inhibition by DTNB. Removal of both cysteines
simultaneously further diminished this inhibition, but did
not eliminate it completely. Hence, DTNB interacts with
multiple sites on the CaV3.1 channel. In accord with this
assumption the roughly estimated Hill coefficient for the
WT channel is 1.8 suggesting positive cooperativity
between multiple binding sites. The Hill coefficient
provides only a minimum estimate of interaction sites
involved [32]. Cysteines C298 and C313 are part of these
interaction sites, however, our data do not allow to
distinguish if each of them is part of separate sites or both
are part of the same site.
The importance of domain I in CaV3 gating is underlined
by mutations related to childhood epilepsy. A gain-of-
function point mutation was discovered in the proximal I–II
loop of the CaV3.2 channel [12]. This mutation destabilizes
the closed state of CaV3.2. Such a scenario is supported by
the recent discovery of a “gating brake” in the I–II loop of
CaV3.2 [1, 31], which is conserved in all three CaV3
channels [2] and prevents CaV3 channels from opening at
membrane voltages close to cell resting potential. These
Table 3 Effects of DTNB on current amplitude and voltage dependence of current activation
Channel construct Control 2.5 mM DTNB ICa inhibition(%)
V0.5 (mV) dV (mV) V0.5 (mV) dV (mV)
WT −49.9±0.8 (12) 3.3±0.2 −52.4±1.0** 3.4±0.3 99±1 (6)
C298A −42.8±1.3 (6) 6.2±0.3 −33.6±1.6*** 8.6±0.3** 50±3 (6)
C313A −43.4±1.8 (10) 5.8±0.7 −38.2±2.6** 6.8±0.5 52±4 (6)
C298/313A −44.9±1.1 (5) 4.2±0.5 −37.9±1.5** 6.4±0.5*** 38±3 (10)
Voltage dependences of activation for WT, C298A, C313A, and C298/313A channels either under control conditions or in the presence of DTNB
were fitted with Eq. 2. Resulting half-maximal voltages (V0.5) and slope factors dV are listed together with the numbers of tested cells in brackets.
In case of WT channel concentration of DTNB was 1 mM. The inhibition of the amplitude of calcium currents evoked by 50 ms depolarization
from −100 mV to −30 mV by 2.5 mM DTNB is listed in the last column. The number of cells tested is indicated in brackets. Inhibition of the
double mutant C298/313A was significantly different from inhibition of both C298A and C313A (p<0.05)
***p<0.001; **p<0.01 (significant differences between control and DTNB)
Fig. 7 Homology model of CaV3.1 with ab initio EC loop I. a Ribbon
representation (side view) of the CaV3.1 structure model with the
extracellular loop connecting IS5–IP, generated with I-Tasser shown
on top (gray, surface representation). Domain I (S1–S6) is colored
green, domain II is shown in blue, the color of domain III is purple,
and domain IV is shown in orange. Extracellular cysteines are shown
as spheres. Due to the lack of modeling constraints, both segments are
not connected. The lipoic acid and DNTB interaction site as inferred
from studies on CaV3.2 [9] is indicated with arrows. b Ribbon
representation (top view) of the CaV3.1 model with EC loop I colored
gray. The color scheme is identical as in (a)
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studies suggest that pore region of the domain I is an
important determinants of CaV3 channels activation and
inactivation. Loop connecting domains I and II have
previously been shown to play a key role in inactivation
of high-voltage-activated calcium channels CaV2.3 [3, 25],
CaV1.2 [3, 9], and CaV2.1 [4, 5, 9]. Further, self-reliant
molecular determinants of channel activation were discov-
ered in a region responsible for association with the beta
subunit in the I–II loop of CaV1.2 and CaV2.3 channels [7].
However, the I–II linker of CaV3 channels has a low degree
of homology with the corresponding linker in high-voltage-
activated channels making an extrapolation of mutational
studies in this region difficult.
Our results point to essential role of all cysteines in the
IS5-P loop in channel gating. The question whether they
form disulfide bonds within this loop or with cysteines in
other channel domains remains open. To evaluate this
possibility we have designed a homology model of the
CaV3.1 pore domain and included the extracellular loop
connecting IS5 and P segments, by means of ab initio
modeling. Ab initio methods are not yet accurate enough to
distinguish between various possible disulfide bonds, since
different cysteine bridges were observed in seven out of the
ten generated models. However, three of the generated
models support a scenario, where replacement of one
cysteine involved in disulfide bridge formation by alanine
would lead to the formation of an alternative cysteine
bridge (see Supplementary Figure 3).
The homology model of the pore domain (I–IV S1–S6)
shows which of the many cysteines are located on the
extracellular side of the protein and thereby possibly
accessible for interactions with the extracellular loop I
(Fig. 7). The CaV3.1 model suggests that cysteines located
in the loop connecting helix IIIS5 and IIIP, and cysteines in
the loops connecting IVS5 and IVP and the loop connecting
IVP and IVS6 might be possible interaction candidates for
cysteines from the EC loop I. Such possible disulfide bonds
can be tested in future experiments and might improve the
quality of the models considerably.
The reducing agent DTT acts either by breaking existing
disulfide bonds and/or by scavengingmetal ions thus relieving
current inhibition. The observed shift of the activation curve
and moderate enhancement of calcium current at voltages
negative to the peak of the I–V curve in mutant channels is
consistent with a model in which cysteines C298 and C313
form bridges with some other cysteines. Their replacement
either individually or simultaneously frees their interaction
partner, which then can be involved in inhibition by an
unknown ion. Such inhibition is consistent with observed
changes in channel gating observed in mutant channels. DTT
application relieves this inhibition by its scavenger effect.
This suggestion is supported by observed restoration of
channels activation gating.
Reduced current inhibition by DTNB seems to be in
contradiction with the hypothesis that cysteines C298 and
C313 form disulfide bonds. Both participate in the
interaction with DTNB, which is a specific thiol oxidizing
agent. Nevertheless, disulfide bonds formed by oxidizing
thiol groups are relatively stable. Rapid reversibility of
current inhibition by DTNB suggests that other mechanism
than direct binding to –SH group underlies this effect.
The present study is, to our knowledge, the first to
analyze the role of individual cysteine residues in the IS5-P
loop of the CaV3.1 channel. Our data suggest that all
mutated cysteines are essential for proper channel gating.
Additionally, we have identified new residues involved in
redox regulation of the CaV3.1 channel.
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Supplementary Table 1. 
 
Significance of differences in time constants of channel’s activation and inactivation. WT and 
mutants were compared by unpaired t-test. n.s. – not significant; * - p < 0.05; ** - p < 0.01; *** - 
p < 0.001. 
 
V (mV) 
τact τinact 
C298A C313A C298/313A C298A C313A C298/313A 
-45 n.s. n.s. n.s. - - - 
-40 n.s. n.s n.s. *** *** *** 
-35 *** *** ** *** ** *** 
-30 *** *** ** ** n.s. ** 
-25 *** *** *** ** n.s. * 
-20 *** *** *** ** n.s. * 
-15 *** *** *** * n.s. * 
-10 *** *** *** ** n.s. * 
-5 *** ** *** * n.s. * 
0 *** * - * n.s. * 
 
3 
 
Supplementary Table 2. 
 
Significance of differences in deactivation time constants. WT and mutants were compared by 
unpaired t-test. n.s. – not significant; * - p < 0.05; ** - p < 0.01; *** - p < 0.001. 
 
V (mV) 
τdeact 
C298A C313A C298/313A 
-140 n.s. ** - 
-130 n.s. ** ** 
-120 n.s. * ** 
-110 n.s. *** ** 
-100 n.s. *** ** 
-90 n.s. *** ** 
-80 n.s. *** ** 
-70 n.s. *** ** 
-60 * *** *** 
 
4 
 
Supplementary Figure 1. Sequence alignment of Cav3.1, Cav3.2, NaChBac and Kv1.2.  
The alignment of the full pore domain (S1- S6) of CaV3.1 (Accession number: O43497), CaV3.2 
(Accession number: O95180), Cav3.3 (Accession number: Q9P0X4), NaChBac (Accession 
number: Q9KCR8) and KV1.2 (PDB IDs: 2r9r, 3lut) is shown. Residues conserved in all 
channels are shaded dark gray, similar residues in all sequences are shaded light gray and highly 
conserved cysteines are shaded black. All other cysteine residues are underlined. The 
approximate membrane boundaries, as well as extra- (EC) and intracellular (IC) location of 
residues are indicated above the alignment. 
 
Supplementary Figure 2. Membrane localization of expressed channel proteins. 
The first column demonstrates the subcellular distribution of the wild type (WT) CaV3.1 channel 
as well as C271A, C298A and C313A mutant constructs visualized by EGFP fused to their 
carboxy-terminus. The second column shows the membrane staining by the FM4-64 protein. The 
third column represents an overlap of the two previous columns. Colocalization of EGFP fusion 
and FM4-64 proteins is visualized in yellow. 
 
Supplementary Figure 3. Hypothetical cysteine bridge formations in ab initio loop model  
Detailed view of hypothetical cysteine bridge formations based on a Tasser ab initio loop model. 
In this model 3 cysteines (shown as sticks) are in close proximity and mutation of one cysteine to 
an alanine could possibly promote the switch between cysteine bridges. SH-groups of cysteine 
residues are coloured yellow, nitrogen atoms are shown in blue and carbon atoms are coloured 
grey. 
  
  
 
 
     EC loop I shown in Fig. 1 (main manuscript) 
 
Sequence alignment of Cav3.1 (hs), Cav3.2 (hs), NaChBac and Kv1.2. 
 
 
 
 
Suppl fig 1 
 IC membrane EC 
               ---------S1-------- 
Cav3.1 I   RTVCNPWFERISMLVILLNCVTLGMFRPCEDIAC 
Cav3.2 I   RLVCNPWFEHVSMLVIMLNCVTLGMFRPCEDVEC 
Cav3.1 II  KIVDSKYFGRGIMIAILVNTLSMGIEYHEQPEEL 
Cav3.2 II  RIVDSKYFSRGIMMAILVNTLSMGVEYHEQPEEL 
Cav3.1 III RIITHKMFDHVVLVIIFLNCITIAMERPKIDP-- 
Cav3.2 III KVITHKMFDHVVLVFIFLNCVTIALERPDIDP-- 
Cav3.1 IV  HLCTSHYLDLFITGVIGLNVVTMAMEHYQQPQIL 
Cav3.2 IV  SLCTSHYLDLFITFIICVNVITMSMEHYNQPKSL 
NaChBac    KIVNHRAFTFTVIALILFNALIVGIETYPRI--- 
Kv1.2      SSGPARIIAIVSVMVILISIVSFCLETLPIFRDE 
 EC membrane IC 
             -----------S2----------- 
Cav3.1 I  DSQRCRILQAFDDFIFAFFAVEMVVKMVALGLFGQK 
Cav3.2 I  GSERCNILEAFDAFIFAFFAVEMVIKMVALGLFGQK  
Cav3.1 II  ----TNALEISNIVFTSLFALEMLLKLLVYGPF--- 
Cav3.2 II  ----TNALEISNIVFTSMFALEMLLKLLACGPL--- 
Cav3.1 III HSAERIFLTVSNYIFTAIFVGEMTLKVVALGWCFGE 
Cav3.2 III GSTERVFLSVSNYIFTAIFVAEMMVKVVALGLLSGE 
Cav3.1 V  ----DEALKICNYIFTVIFVLESVFKLVAFGFR--- 
CAv3.2 IV  ----DEALKYCNYVFTIVFVFEAALKLVAFGFR--- 
NaChBac   YADHKWLFYRIDLVLLWIFTIEIAMRFLASNPKS--  
Kv1.2     STSFTDPFFIVETLCIIWFSFEFLVRFFACPSKA-- 
IC membrane EC 
               --------S3-------     
Cav3.1 I   CYLGDTWNRLDFFIVMAGMVEYSLDLQN 
Cav3.2 I   CYLGDTWNRLDFFIVVAGMMEYSLDGHN 
Cav3.1 II  GYIKNPYNIFDGVIVVISVWEIVGQQGG 
Cav3.2 II  GYIRNPYNIFDGIIVVISVWEIVGQADG 
Cav3.1 III AYLRSSWNVLDGLLVLISVIDILVSMVS 
Cav3.2 III AYLQSSWNLLDGLLVLVSLVDIVVAMAS 
Cav3.1 IV  RFFQDRWNQLDLAIVLLSIMGITLEEIE 
Cav3.2 IV  RFFKDRWNQLDLAIVLLSLMGITLEEIE 
NaChBac    AFFRSSWNWFDFLIVAAGHIFAGAQF-- 
Kv1.2      GFFTNIMNIIDIVAIIPYFITLGTELAE 
EC membrane IC 
               -------S4-----------L45---- 
Cav3.1 I   ----VSFSAVRTVRVLRPLRAINRVPSMRILVTLLLDT 
Cav3.2 I   ----VSLSAIRTVRVLRPLRAINRVPSMRILVTLLLDT 
Cav3.1 II  -----GLSVLRTFRLMRVLKLVRFLPALQRQLVVLMKT 
Cav3.2 II  -----GLSVLRTFRLLRVLKLVRFLPALRRQLVVLVKT 
Cav3.1 III TKILGMLRVLRLLRTLRPLRVISRAQGLKLVVETLMSS 
Cav3.2 III AKILGVLRVLRLLRTLRPLRVISRAPGLKLVVETLISS 
Cav3.1 IV  PINPTIIRIMRVLRIARVLKLLKMAVGMRALLDTVMQA  
Cav3.2 IV  PINPTIIRIMRVLRIARVLKLLKMATGMRALLDTVVQA 
NaChBac   ------VTVLRILRVLRVLRAISVVPSLRRLVDALVMT 
Kv1.2     AMSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKAS 
IC membrane EC 
                -----------S5---------- 
Cav3.1 I   LPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCF-- 
Cav3.2 I   LPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCF-- 
Cav3.1 II  MDNVATFCMLLMLFIFIFSILGMHLFGCKFASERD--  
Cav3.2 II  MDNVATFCTLLMLFIFIFSILGMHLFGCKFSLKTDTG 
Cav3.1 III LKPIGNIVVICCAFFIIFGILGVQLFKGKFFVCQGED 
Cav3.2 III LRPIGNIVLICCAFFIIFGILGVQLFKGKFYYCE--- 
Cav3.1 IV  LPQVGNLGLLFMLLFFIFAALGVELFGDLECDETHPC 
Cav3.2 IV  LPQVGNLGLLFMLLFFIYAALGVELFGRLECSEDNPC 
NaChBac    IPALGNILILMSIFFYIFAVIGTMLFQHVSPE----- 
Kv1.2      MRELGLLIFFLFIGVILFSSAVYFAEADERDS----- 
EC  membrane EC 
                   ---------P---------- 
Cav3.1 I   NPFKGAINFDNIGYAWIAIFQVITLEGWVDIMYF--- 
Cav3.2 I   NPHNGAINFDNIGYAWIAIFQVITLEGWVDIMYY--- 
Cav3.1 II  DTLPDRKNFDSLLWAIVTVFQILTQEDWNKVLYNG-- 
Cav3.2 II  DTVPDRKNFDSLLWAIVTVFQILTQEDWNVVLYN--- 
av3.1 III RWVRHKYNFDNLGQALMSLFVLASKDGWVDIMYDGSL 
av3.2 III RWVRRKYNFDNLGQALMSLFVLSSKDGWVNIMYD--- 
Cav3.1 IV  EGLGRHATFRNFGMAFLTLFRVSTGDNWNGIMKDTLR 
Cav3.2 IV  EGLSRHATFSNFGMAFLTLFRVSTGDNWNGIMKD--- 
NaChBac    -------YFGNLQLSLLTLFQVVTLESWASGVMR--- 
Kv1.2      -------QFPSIPDAFWWAVVSMTTVGYGDMVP---- 
EC membrane IC 
                ------------S6------------- 
Cav3.1 I   VMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSE 
Cav3.2 I   VMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSE 
Cav3.1 II  GMASTSSWAALYFIALMTFGNYVLFNLLVAILVEGFQA 
Cav3.2 II  GMASTSSWAALYFVALMTFGNYVLFNLLVAILVEGFQA 
Cav3.1 III PIMNHNPWMLLYFISFLLIVAFFVLNMFVGVVVENFHK 
Cav3.2 III PVQNHNPWMLLYFISFLLIVSFFVLNMFVGVVVENFHK 
Cav3.1 IV  -TCYNTVISPIYFVSFVLTAQFVLVNVVIAVLMKHLEE 
Cav3.2 IV  CLSYLPALSPVYFVTFVLVAQFVLVNVVVAVLMKHLEE 
NaChBac    PIFAEVPWSWLYFVSFVLIGTFIIFNLFIGVIVNNVEK 
Kv1.2      ----TTIGGKIVGSLCAIAGVLTIA-LPVPVIVSNFNY 
Colour Code :  
Highly-conserved cysteines in T-type Cav 
Identical amino acids in Cav, NaChBac and Kv1.2 
Similar amino acids in Cav, NaChBac and Kv1.2 
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3.4 Docking studies of Phenylalkylamines (PAAs) verapamil and its derivatives to the open 
conformation of Cav1.2. 
Molecular docking of PAA verapamil and its derivatives was performed to the Cav1.2 
open conformation taken from Stary et al, 2009. The binding site of PAA verapamil are in 
particular located in transmembrane helices IIIS6, IVS6 and P-loops of repeats III and IV. The 
following amino acids Y1180, I1181, F1191 and V1192 in IIIS6, Y1490, M1491, A1494 and 
I1491 in IVS6 and E1145 and E1446 in the selectivity filter of domains III and IV were 
considered in this docking  [40, 42, 90].   
The PAA verapamil and its derivatives (see chapter 1.9) were built with Gauss View 
program in protonated states of both, R and S chirality and optimized with the Hartree-Fock 3-
21G basis set implemented in Gaussian03. Due to the flexible conformation of the ligands, the 
concrete interact ion with the channel is uncertain. Then, each of the ligands was generated in 
different conformations using the conformation search option in MOE program. The first 10 
conformations were selected using energy criteria.  
 
1 
130.609 
2 
130.954 
3
131.153 
4
131.152 
5 
131.598 
6 
132.451 
7 
132.676 
8
132.981 
9
133.059 
10 
133.239 
 
 
Fig 3.4. The 10 different conformations of S chirality verapamil which were selected using 
energy criteria. 
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1 
144.270 
2 
144.712 
3
145.533 
4
146.412 
5 
146.542 
6 
146.591 
7 
147.240 
8
147.815 
9
148.094 
10 
148.556 
 
Fig 3.5. The 10 different conformations of S chirality D490 which were selected using energy 
criteria. 
 
1 
79.915 
2 
82.310 
3 
83.424 
4 
83.527 
5           
83.811 
 6 
84.370 
7 
85.140 
8 
85.139 
9 
85.304 
10 
82.969 
 
Fig 3.6. The 10 different conformations of S chirality D619 which were selected using energy 
criteria. 
The examples of 10 ranked conformations of each group of PAA verapamil are shown: 
Group A verapamil-S chirality (shown in Fig 3.4), Group B D490-S chirality (shown in Fig 3.5) 
and Group C D619-S chirality (shown in Fig 3.6).  
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3.4.1 Docking studies and molecular dynamic simulations of verapamil(S) in a open 
conformation of Cav1.2. 
Table 3.2 illustrates a summary of the best scorings from 10 different starting 
conformations of verapamil(S). For each conformation 100 poses were analysed. Lipkind et al, 
2003 [91] proposed that the PAA drugs occupy and occlude the interface of III/IV crevice by 
adopting the half-folded conformation shapes. The superimposition of the first ranking of each 
conformation of verapamil(S) demonstrated that verapamil(S) is located between domains III 
and IV (Fig 3.7). The docking results as shown in Fig 3.8 revealed that almost all the best poses 
from each different starting conformation form the half-folded shapes with the channel except 
the 6th and the 7th conformation which form the extended shape.  
 
Table 3.2 Glide scoring functions of 10 different S chirality verapamil conformations. 
 
Conformation GScore Lipo HBond vdW Coul 
1 -5.23 -2.10 -0.1 -35.1 -10.9 
2 -5.40 -1.90 0 -39.01 -12.89 
3 -5.29 -2.00 0 -38.3 -11.2 
4 -5.60 -2.30 -0.3 -34.9 -10.2 
5 -5.10 -1.30 -0.2 -36.0 -13.9 
6 -5.45 -2.30 0 -40.5 -8.4 
7 -5.28 -1.60 -0.4 -32.5 -13.5 
8 -5.59 -1.90 -0.3 -42.2 -11.3 
9 -5.51 -2.30 -0.1 -36.1 -9.60 
10 -5.05 -1.90 -0.1 -33.0 -10.9 
 
Note: The protocol explanation in Chapter 2.3.1. 
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Fig 3.7. Superimposition of first rankings of each conformation of verapamil(S). Each verapamil 
show in grey stick. Each domain of S6 is colored: blue (IS6), brown (IIS6), purple (IIIS6) and 
green (IVS6).  
 
A molecular dynamic simulation of the pore region of Cav1.2 in open conformation with 
verapamil complexed was generated and the system was simulated for 40 ns. The first docking 
pose of verapamil conformation 4th which is the best ranking of all 10 different conformations 
was selected to start the simulation.  
 
(a)   The 1st conformation.    (b)   The 2nd conformation.                                             
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(c)   The 3rd conformation.    (d)   The 4th conformation. 
 
  
 
  
 
 
 
 
 
(e)   The 5th conformation.   (f)   The 6th conformation. 
 
 
(i)   The 7th conformation.    (g)   The 8th conformation. 
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(k)   The 9th conformation.   (h)   The 10th conformation. 
 
Fig 3.8. The 3D diagrams showing the interaction between verapamil(S) and surrounding 
residues. The verapamil(S) are presented in red stick. The surrounding residues are shown in 
gray stick and ball. Binding residues are shown in gray line. The yellow ball is representing the 
Ca2+. 
 
The stability of the verapamil complex was analyzed using the root-mean-square 
displacement (RMSD). The conformational change of the protein during the simulation can be 
indirectly described by RMSD values. The backbone RMSD value of the pore region of the open 
conformation of Cav1.2 steadily increases over 40ns (Fig 3.9 a). The RMSD value of each 
domain was calculated as shown in Fig 3.9 b. For domain I and II, the RMSD values still 
increase. The RMSD value of domain III and IV steadily increases for the first ns and then stably 
remains at 0.15 nm. It is implied that domains I and II are responsible for instability of the pore 
region.  
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(a)        (b) 
Fig 3.9. RMSD values of (a) the pore region backbone of Cav1.2 in open conformation (b) each 
domain backbone. Domains I, II, III and IV are shown in black, red, green and blue, respectively. 
 
The RMSD of verapamil was obtained.  Fig 3.10 shows that the RMSD value of 
verapamil in complex has a fluctuation during the whole simulation. These plots indicate that the 
pore region complex with verapamil shows some instability which might be because of the 
model or the binding residues are not sufficient and good enough. 
 
 
Fig 3.10. RMSD values of Verapamil over 40 ns simulation.  
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3.4.2 Docking studies of three groups of verapamil derivatives with open conformation of 
Cav1.2. 
These docking studies focus on details of the interaction between drug and the pore 
region of the open channel. In particular, molecular docking for verapamil’s derivatives to the 
open channel have been performed and the results have been compared with the experimental 
data and hypotheses of other groups. The summary of the best docking poses of group A, B and 
C in S and R conformation with open conformation of Cav1.2 are demonstrated in Table 3.3.   
 
Table 3.3 The Glide scoring function of the docking of each protonated ligand in R and S 
conformation to the open conformation of Cav1.2. 
 
Group A 
Title GScore Lipo HBond vdW Coul 
S conformation 
Verapamil -5.60 -2.30 -0.3 -34.9 -10.2 
D600 -5.41 -1.10 -0.5 -38.6 -15.4 
D557 -5.98 -1.30 -0.4 -37.7 -17.2 
D595 -5.76 -2.70 0.0 -36.3 -8.2 
T13 -5.86 -1.50 -0.3 -34.0 -14.6 
PR23 -6.77 -2.90 0.0 -31.8 -17.8 
D559 -6.24 -3.91 0.0 -31.5 -6.8 
R conformation 
Verapamil -5.84 -1.1 -0.8 -32.6 -32.6 
D600 -5.41 -2.4 -0.3 -28.0 -10.5 
D557 -6.46 -1.1 -0.6 -35.0 -20.0 
D595  -6.10 -2.0 -0.6 -36.8 -11.8 
T13 -5.97 -1.4 -0.2 -34.0 -16.7 
PR23 -6.40 -2.09 0.0 -31.8 -19.4 
D559 -6.37 -2.96 -0.3 -39.8 -7.3 
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Group B 
Title GScore Lipo HBond vdW Coul 
S conformation 
D490PS -7.41 -4.2 0.0 -47.2 -9.4 
D586PS -6.99 -3.4 -0.4 -44.3 -12.0 
D525PS -6.57 -2.9 -0.2 -38.3 -12.1 
R conformation 
D490PR -6.48 -3.9 0.0 -50.3 -4.6 
D586PR -7.32 -4.1 0.0 -47.5 -9.6 
D525PR -6.19 -3.0 -0.2 -37.8 -9.3 
 
 
Group C 
Title GScore Lipo HBond vdW Coul 
S conformation 
D594PS -6.57 -3.1 0.0 -43.17 -12.37 
PR22PS -6.59 -3.4 0.0 -37.0 -10.7 
D619PS -6.00 -1.8 0.0 -27.8 -14.0 
H1PS -6.36 -2.5 -0.5 -37.6 -12.4 
R conformation 
D594PR -6.81 -3.3 -0.3 -40.4 -11.32 
PR22PR -6.34 -2.7 -0.2 -36.9 -12.5 
D619PR -5.35 -2.6 0.0 -27.8 -5.0 
H1PR -6.82 -3.0 -0.6 -37.3 -12.0 
 
Note GScore  =  Glide Score ( kcal/mol ) 
 Lipo   =  Lipophilic-contact plus phobic-attractive term 
 HBond  = Hydrogen-bonding term 
 vdW   = van der Waals interaction energy 
 Coul   = Coulomb interaction energy 
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Fig 3.11. Side view of the PAA drug binding in open conformation of Cav1.2 homology model. 
 
Cheng et al 2009 [92] suggested a geometry of the PAA – L-type calcium channel 
complexes, where  the meta-methoxy group in the benzene ring near the ammonium group 
accepts the H-bond from Y1180, and the meta-methoxy group of another benzene ring accepts 
the H-bond from Y1490. From the results, it is shown that all drugs share similar orientation and 
position where the ligands are located between IIIS6 and IVS6 as shown in Fig 3.11 [91]. The 
positively charged nitrogen atoms of all ligands bind to the glutamic acids E1145 and E1446 due 
to the electrostatic interactions (Fig 3.12).  
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         (a)      (b)  
 
 
  
            (c)                (d)  
 
Fig 3.12. The best docking poses of (a) Group A- verapamil (b) Group A- D600 (c) Group B- 
D525 (d) Group C- H1.  Each ligand are shown in grey sticks.  IIIS6 is colored in purple and 
binding residue along the IIIS6 is shown as stick in purple.  IVS6 is colored in green and binding 
residue along the IVS6 is shown as stick in green. The yellow ball is representing Ca2+. 
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However, almost all binding residues are in some cases not facing into the pore. 
Especially, Y1152 and Y1463 do not interact with the drug (Fig. 3.13). It might be due to the 
template is still not good enough. Therefore the results of Cav1.2 open conformation model with 
verapamil and its derivatives obtained from molecular docking is in disagreement with 
experimental data. Also the molecular dynamic simulation of the open conformation of the 
channel with verapamil is not stable. Further studies are needed with an improved refinement of 
the homology model based on drug interaction data.  
 
Group A 
   
S      R 
 
Group B 
   
S      R 
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Group C 
  
S      R 
 
Fig 3.13. The superimposition of the best poses from docking. The PAA are presented in grey 
sticks. The binding residues at domain III and IV are shown in purple and green sticks. 
 
3.5 Stability of the pore region of Cav1.2 in closed conformation and in improved open 
conformation. 
Consequently, because of the inconsistency of docking results of the MD results and in 
particular the experimental data for open conformation of Cav1.2, the homology model of this 
channel was modified and improved [9] by H.R. Guy. The improvement of the open structure 
was mainly at III-P helix by shifting it slightly outward (Fig. 3.14a). From the improved model, 
it is shown that the binding residue Y1490 slightly moves facing into the pore, Y1180 and F1191 
are slightly shifted too, which should improve the interaction between drug and the new model 
(Fig. 3.14b).    
To refine the structures of the closed and the improved open models, 2 ns of restrained 
position and the 50 ns of unrestrained molecular dynamics simulations was performed.  The 
stability of both systems are analyzed by RMSD (root mean square deviation). The RMSD of 
closed and improved open channels in POPC are around 0.3 nm as show in Fig 3 of Summary 1.   
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(a) (b) 
 
Fig. 3.14. Superimposition of the published homology model of the open conformation of the 
channel and the improved homology model. (a) Domain III-P helix (b) Domain IIIS6 and IVS6 
are presented in purple and green, respectively.  The binding residues of published model are 
shown in grey sticks. The binding residues of improved model on domain IIIS6 and IVS6 are 
shown in purple and green sticks. 
 
3.6 Molecular Dynamics simulation studied of the improved open conformation of Cav1.2 
calcium channel with verapamil and some of its derivatives.  
 MD simulation of verapamil and some of its derivatives were carried out to check the 
stability of the complex and examine conformational variations of verapamil and some of its 
derivatives.  The starting structure of verapamil and the derivatives were taken from the good 
pose docking structures which were obtained by the program GLIDE.  
 
3.6.1 Molecular Dynamics simulations studies of the improved open conformation of Cav1.2 
calcium channel with verapamil 
  The stability of the system was investigated using RMSD of Cα atoms of the protein (Fig 
3.15a) and the Cα atoms of each domain (Fig 3.15b) as a function of the simulation time. The 
RMSD values of protein rose to 0.27 nm and were relatively stable after 7 ns.  During the first 7 
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ns the RMSD values are increased to 0.2 nm for domain I and II, 0.25 nm for domain II and IV 
and remain stable. This simulations show that the pore region of the improved open 
conformation is well behaved and rather stable after 7 ns.  
 
 
(a)          (b) 
 
Fig 3.15. RMSD values of (a) backbone of the pore region of the open conformation (b) 
backbone of each domain. Domain I, II, III and IV are shown in black, red, green and blue, 
respectively. 
  
 
Fig 3.16. RMSD values of Verapamil in the pore region of the open conformation. 
 
To insight the information on the ligand, the RMSD and RMSF values of verapamil were 
calculated. Fig 3.16 shows that the RMSD of verapamil remains stable at 0.25 nm after 2 ns. The 
fluctuation of each verapamil atom during 2 – 20 ns was investigated in terms of root mean 
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square fluctuation (RMSF).  From Fig 3.17a, it can be seen that the fluctuation of the benzene 
ring, the ammonium group and the nitrile group of verapamil are small. The highest flexibility 
was exhibited at the hydrogen atoms that are surrounded by green circle as shown in Fig 3.17b. 
They belong to methyl groups, which have in general a larger mobility because of the rotation of 
the single bond. The RMSD and RMSF profile characterized that, after an initial increase in the 
magnitude of verapamil atoms fluctuation, the verapamil reached an equilibrium state. 
 
 
(a)   
 
 
 
(b) 
 
Fig 3.17. (a) RMSF values of Verapamil in pore region or the open conformation. (b)  2D 
structure of Verapamil. Green circle indicate the hydrogen atoms of highest flexibility. 
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The results from MD simulation suggest that the structure of the improved open 
conformation of Cav1.2 is more stable and suitable for the description of the PAA verapamil 
complex than the previous open conformation.  Thus, this improved structure was used for 
further studies of verapamil derivatives.  
 
3.6.2 Molecular Dynamics simulation studies of the improved open conformation of Cav1.2 
calcium channel with D619 and T13  
 The verapamil derivative D619 of group C and T13 of group A was selected to gain 
insight into the structural and dynamic features of this ligand-receptor interaction. MD 
simulations of D619 and T13 were carried out from 5 (D619) and 2 (T13) initial orientations of 
the ligands. Analysis of the RMSD of the Cα atoms showed that all simulations reached an 
equilibrium after 15 ns (Fig. 3.18 a and c).  Additionally, the RMSD of D619 and T13 remained 
at small fluctuations after 15 ns of the simulation giving further confirmation of the stability of 
the simulation (Fig. 3.18 b and d).  
  
 
(a)          (b) 
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(c)         (d) 
 
Fig 3.18. RMSD values of (a) backbone of the improved pore region of the open conformation of 
D619 complex. (b) D619 in the pore region of the open conformation. Each 5 different starting 
positions of D619 are shown in black, red, green, blue and yellow, respectively. (c) backbone of 
the improved pore region of the open conformation of T13 complex. (d) T13 in the pore region 
of the open conformation. Each of the two different starting positions of T13 are shown in black 
and red. 
 
RMSF analyses of the ligands between 15 to 20 ns were also performed. Most of the 
flexible parts of D619 and T13 can be seen as peaks in the Fig 3.19 a and c. The hydrogen and 
fluorine atoms are circled in green as shown in Fig 3.19 b and d show that the hydrogen atoms 
which belong to methyl group are higher fluctuation than the other atoms. It is also indicated that 
the benzene ring, the ammonium group and the nitrile group are rather rigid.  
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(a)          (b) 
 
 
(c)          (d) 
 
Fig 3.19. (a) RMSF values of D619 in open conformation of Cav1.2. (b)  2D structure of D619. 
(c) RMSF values of T13 in open conformation. (d)  2D structure of T13. Green circle indicate 
hydrogen atoms of the highest flexibility. 
 
 The superimposition of the average structures of D619 and T13 complex of the last 5ns 
of MD simulation with initial models does show ligand conformation changes in each different 
run (Fig 3.20 and 3.22). The initial structure was randomly started from 5 different positions for 
D619 and 2 different positions for T13 in the cavity. The information obtained from these 
simulations found that D619 and T13 are located between the domains III/IVS6. For D619, the 
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benzene ring faces to IIIS6 or either to IVS6. In the T13 complex system, each benzene ring 
binds to each domain IIIS6 and IVS6. The average structure from MD simulation supports the 
hypothesis that the benzene ring as a part of the ligand should interact with IIIS6 and/or IVS6.  
    
 
(a)    (b)    (c)  
 
 
(d)    (e) 
 
Fig 3.20.  Superposition of the initial D619 complex structure (gray) and the averaged structures 
of the last 5ns of MD simulation complexes. The domain IIIS6 (pink) and IVS6 (green) are also 
given. The position of the ligand D619 after docking and the average structure from MD 
simulation are shown in gray and orange sticks. (a) 1st run. (b) 2nd run (c) 3rd run (d) 4th run (e) 5th 
run. 
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(a)    (b) 
 
 
(c)    (d) 
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    (e)     
 
 
 
Fig 3.21.  The interaction between D619 and receptor from averaged structures of the last 5ns of 
MD simulation using MOE program. (a) 1st run (b) 2nd run (c) 3rd run (d) 4th run (e) 5th run. In (b) 
and (c) are shown an arene-cation interaction with Phe1144. 
 
Each simulation of D619 in the complex results in a binding pattern by using MOE 
program as shown in Fig 3.21. The interaction between protein and ligand mainly involves 
hydrophobic interactions which hydrophobic residues shown by green circles. It can be seen 
from the Fig 3.21 b and e that the positively charged nitrogen atom of D619 interacts with the 
aromatic ring of Phe 1144, which is the residue before the selectivity filter residue on domain III 
(TFE).  The annotation also shows a high degree of reduction of solvent-exposed surface area (a 
halolike disc around the residue) on Phe1144 which indicates a favorable stabilizing interaction. 
In most simulation runs of the D619 complex the positively charged nitrogen points outwards 
from the binding pocket, this is indicated by a blue surface. Only in the 5th run, there is an 
interaction of this group with on amino acid of the pocket (Phe1144) (Fig 3.21 e). 
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             (a)                      (b) 
 
           
 
            (c)                  (d) 
 
Fig 3.22.  (a) Superpositions of the 1st run. The initial T13 complex structure (gray) and the 
averaged structures of the last 5ns of MD simulation complexes in contact with IIIS6 (pink) and 
IVS6 (green) are shown. The T13 ligand from docking and from averaged structure of MD 
simulation is shown in sticks in gray and orange. (b) 2nd run. The 2D diagram of the interactions 
between T13 and receptor results from averaged structures of the last 5ns of MD simulation.  
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 The ligand T13 is fitting to binding pocket, which is shown by the contour line (Fig 
3.22). Fig 3.22b shows that the π-cation interaction between the positively charged nitrogen atom 
of T13 and Phe1144 is present. Additional, it is also interesting to note that all of the receptor 
residues located on one side of the T13 point out of the binding residues. In the 2nd run as shown 
in Fig 3.18, the starting position of T13 was at the middle of the pore. The ligand T13 from 
averaged structure of the last 5 ns of simulation were still located around the center of the pore. 
From these five and two different starting positions of D619 and T13 ligand, it can be 
seen that the difference of the starting positions of the ligand is important.  Different geometries 
are obtained from these simulations which appear to be stable throughout the whole simulation 
time. This implies that MD is not suitable to distinguish between different starting poses 
probably because simulation times are not long enough and or the model is not good enough. 
This remarkable result needs some further investigation. Particular supporting experimental data 
are needed.  
 
3.7 Molecular Dynamics simulation studies of the improved open conformation of Cav1.2 
calcium channel with quaternary (-) diltiazem  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.23.  Stability of refined Cav1.2 homology model in MD 
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The quaternary (-) diltiazem (qDil) chemically belongs to the benzothiazepines BTZ 
which is also inhibiting L-type calcium channels in a state dependent manner [93].  The 
simulation was set to compare the result and to test the quality of the improved model with the 
experimental data from group of Prof. Hering [94]. The stability of the drug-refined model was 
tested in a 40 ns MD simulation. Simulation parameters are similar as previously published by 
Stary et al, 2008. The RMSD (root mean square deviation) of the backbone atoms as a function 
of time is shown in Fig 3.23.  During the first 15 ns the RMSD continually rises to approximately 
0.2 nm and remains stable at this level for the next 25 ns. This value is in good agreement with 
published values for low sequence identity homology models.  
 
3.8 Homology Modeling and model evaluation of pore region Cav1.2 closed conformation 
 
 
  
(a)                                                       (b) 
 
Fig 3.24. Homology models of Cav1.2 closed conformation. (a) Side view detail of  pore domain. 
Each domain is colored: yellow (Domain I), blue (Domain II), pink (Domain III) and red 
(Domain IV). (b) Pore forming subunits. L4-5, S5, P and S6 are colored red, blue, green and 
purple, respectively. 
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The pore domains are formed by 4 homologous subunits and are arranged clockwise. 
Each subunit consists of linker helices L4-5, helices S5, a selectivity filter P segment and S6 
helices as show in Fig 3.24. Starting from the initial homology model of pore region Cav1.2 
closed conformation done by A. Stary  [95] built from KcsA, MlotiK crystal structures and 
homology model of NaChBac, we used a new higher resolution crystal structure of NaK sodium 
channel [88] to improve the initial homology model of pore region Cav1.2 closed conformation. 
The Cav1.2 model in closed conformation was built because in the next step of our work weare 
interested in the channel interaction with cholesterol.  
To increase the precision and accuracy of the models, we applied multiple templates 
approaches. Eight models based on KcsA, Mlotik , NaK and the homology model of NaChBac as 
a template were built. For each model, ten different structures were performed.  Due to the lack 
of conserved residues between potassium and cation NaK channel with Cav1.2 channel at 
selectivity filter P region, the P-helices and the selectivity filter were modeled based on 
homology model of NaChBac which contain the same highly conserved sequence FxxxTxExW 
motif, whereas the S5 and S6 segments were based on all templates. 
The protein quality accuracy of a model related to the accuracy of the model. The 
homology model needs to assess the quality of a model. This implies that the reliability of the 
model obtained from various assessment methods is important for structure determination, 
reasonable for MD simulations and suitable to study drug interaction. Various quality assessment 
methods (Prosa2003, Verify 3D, WHAT_CHECK Packing, Procheck, ProQresLG and ProQres 
MaxSub) were applied to evaluate, validate and screen the quality of all models. The result 
outputs from the checking programs are summarized in Table 3.4. The best values of entire 
structures are highlighted in black.  The scores of structure number 2 of model 1 are favorable 
and ranked as a first ranking from Verify 3D, ProQresLG and ProQres MaxSub with acceptation 
of Prosa2003, WHAT_CHECK Packing and Procheck method. Consequently, this structure is 
chosen for the further work.  
Prosa2003 calculated the z-score of protein which based on known structure from all 
available protein of different sources (X-ray and NMR). It can be used to check that the z-score 
of the input structure is within the range of scores typically found for native protein of similar 
size. The good structure protein supposes to be inside this range and small deviation from the 
statistical average over the known structure. In our structure, the range of all known structure of 
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similar size is between 10 to -15.  Thus, the good structure is indicated the score which is close 
to -2.5.  Verify3D analyzes the compatibly of an atomic model with its own amino acid 
sequence. The scores of Verify3D are shown in percentage term of the satisfactory structure. The 
high percentage is implies to be the good structure. WHAT_CHECK packing judges the quality 
of the structure based on z-score. The good structure reports the positive value. Procheck 
illustrates the percentage in most favored region of Ramachandran plot. Therefore, the higher 
value is the better one. ProQres LG score and MaxSub determine the range of quality in different 
ranges as follow:  
For LGscore  
LGscore > 1.5  fairly good model 
LGscore > 2.5  very good model 
LGscore > 4  extremly good model  
For MaxSub 
  MaxSub > 0.1  fairy good model 
  MaxSub > 0.5  very good model 
  MaxSub > 0.8  extremely good model 
 
Table 3.4 Static quality of Cav1.2 closed conformation. 
Model 1:  KcsA, MlotiK, NaK and homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify 
3D 
WHAT_CHECK
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -0.49 53.88 -0.131 82.5 2.962 0.307 
2 -1.08 72.54 -0.676 84.8 4.312 0.430 
3 -0.84 64.99 -0.075 83.0 3.452 0.355 
4 -0.73 58.7 -0.035 84.8 3.118 0.311 
5 -0.97 57.44 -0.031 83.9 3.063 0.330 
6 -0.14 62.26 -0.049 81.4 2.772 0.292 
7 -0.82 58.49  0.030 82.1 3.249 0.35 
8 -0.05 54.09 -0.106 83.7 3.172 0.355 
9 0.14 66.88  0.229 83.7 3.032 0.335 
10 -0.33 65.41 -0.095 84.4 2.984 0.310 
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Model 2:  KcsA, MlotiK, NaK and only P region of homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify3D WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -1.81 53.04 -0.497 80.9 2.777 0.25 
2 -1.53 54.51 -0.502 82.3 2.374 0.214 
3 -1.21 62.47  0.715 82.8 2.804 0.249 
4 -1.47 50.52 -0.217 82.8 2.81 0.261 
5 -1.36 60.38 -0.715 80.7 2.735 0.265 
6 -1.67 59.12 -0.588 82.1 3.173 0.279 
7 -0.98 55.77 -0.627 80.4 3.314 0.302 
8 -0.99 55.35 -0.731 84.6 2.887 0.276 
9 -0.96 57.44  0.270 80.7 2.639 0.250 
10 0.19 52.41  0.185 80.7 2.438 0.232 
 
Model 3:  KcsA and homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify3D WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -1.03 64.99 0.502 83.9 3.82 0.381 
2 -1.37 55.56 0.134 84.6 3.692 0.377 
3 -0.96 69.18 0.779 83.7 3.83 0.388 
4 -1.44 63.1 0.369 83.7 3.396 0.337 
5 -1.73 69.18 0.280 83.4 3.263 0.365 
6 -1.44 59.54 0.977 83.2 3.579 0.372 
7 -1.02 62.47 0.704 84.8 3.918 0.398 
8 -1.34 59.54 0.128 83.7 3.29 0.361 
9 -1.53 66.67 1.125 84.8 3.221 0.327 
10 -1.62 55.77 0.080 84.6 3.521 0.366 
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Model 4:  KcsA and only P region of homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify3D WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 0.36 29.35 0.606 88.1 2.042 0.170 
2 0.40 47.17 0.113 87.9 2.950 0.279 
3 -0.56 46.12 0.169 87.6 2.659 0.229 
4 0.37 32.91 0.302 84.1 2.349 0.198 
5 0.06 42.35 0.464 87.4 2.222 0.201 
6 -0.16 41.93 0.113 89.0 2.311 0.209 
7 0.09 48.22 0.314 87.4 2.007 0.186 
8 0.17 50.31 0.305 88.1 2.381 0.209 
9 0.52 47.38 0.272 86.7 2.497 0.234 
10 0.00 39.2 0.778 85.5 1.896 0.189 
 
 
 
Model 5:  MlotiK and homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify3D WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -1.79 59.96  0.194 83.2 2.840 0.303 
2 -0.71 55.77 -0.148 85.1 2.775 0.284 
3 -1.34 54.93 -0.113 85.5 3.105 0.313 
4 -1.26 62.68 -0.124 84.1 3.102 0.311 
5 -1.30 56.39 -0.146 86.2 2.837 0.295 
6 -0.69 55.97 -0.110 83.7 2.723 0.268 
7 -1.33 61.84  0.129 85.1 3.166 0.322 
8 -1.38 59.54 -0.005 83.9 2.935 0.308 
9 -1.12 59.12  0.264 85.3 3.071 0.327 
10 -0.39 54.93  0.080 83.7 2.975 0.293 
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Model 6:  Mlotik and only P region of homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify3D WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -0.16 63.73 -0.385 90 2.479 0.238 
2 -0.19 50.73 -0.043 90.4 3.352 0.287 
3 -0.06 49.06 -0.083 88.6 3.064 0.291 
4 0.51 54.30  0.143 89.7 2.947 0.307 
5 0.33 48.64 -0.388 86.9 2.742 0.269 
6 0.27 48.22 -0.232 87.6 2.548 0.253 
7 -0.16 58.70 -0.365 86.9 2.890 0.269 
8 0.10 55.14 -0.177 89 3.022 0.280 
9 0.11 60.17 -0.485 88.8 2.842 0.288 
10 0.17 51.15 -0.057 89.5 3.323 0.334 
 
 
Model 7:  NaK and homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify 
3D 
WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -1.19 61.22  0.564 84.6 2.853 0.297 
2 -1.45 55.35  0.391 82.5 2.734 0.286 
3 -1.41 54.93 -0.113 85.5 2.701 0.286 
4 -1.69 63.94  0.842 82.5 2.992 0.310 
5 -1.29 60.59  0.804 84.1 2.834 0.295 
6 -2.25 54.30  0.185 83.7 2.464 0.277 
7 -1.61 55.77  0.709 84.1 3.011 0.304 
8 -1.34 59.12  0.432 84.4 3.171 0.307 
9 -0.75 58.28  0.367 86.7 2.626 0.257 
10 -2.15 61.84  0.686 84.1 3.183 0.308 
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Model 8:  NaK and only P region of homology model of NaChBac as a template. 
Structure 
no. 
Prosa2003 Verify 
3D 
WHAT_CHECK 
Packing 
Procheck ProQres 
LG score 
ProQres 
MaxSub 
1 -1.81 53.04 -0.497 80.9 2.777 0.250 
2 -1.53 54.51 -0.502 82.3 2.374 0.214 
3 -1.21 62.47  0.715 82.8 2.804 0.249 
4 -1.47 50.52 -0.217 82.8 2.810 0.261 
5 -1.36 60.38 -0.715 80.7 2.735 0.265 
6 -1.67 59.12 -0.588 82.1 3.173 0.279 
7 -0.98 55.77 -0.627 80.4 3.314 0.302 
8 -0.99 55.35 -0.731 84.6 2.887 0.276 
9 -0.96 57.44  0.270 80.7 2.639 0.250 
10 0.19 52.41  0.185 80.7 2.438 0.232 
 
Note:  The best scores from each model are highlighted in gray. The overall best scoring 
structure is highlighted in black.  
 
3.9 Molecular Dynamics simulation studies of the pore region of Cav1.2 in closed 
conformation and improved open conformation in dependence of the content of cholesterol 
in the membrane  
  In this section, we focus on the effect of both models by addition of cholesterol into the 
lipid bilayer. Some part of this work presented and published in European Biophysics Journal 
with Biophysics Letters 40:118-118, 2011 [96].  The possible effects by which cholesterol 
influences Cav1.2 channels see Summary 1.  
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Summary 1  
 
Molecular Dynamics Simulations on the Function of the Transmembrane Cav1.2 Channel 
in Dependence of the Content of Cholesterol in the Membrane 
 
Cholesterol is known to influence voltage-gated calcium channel currents. It has been 
previously shown that increased membrane free cholesterol levels decrease calcium channel 
currents in coronary arterial smooth muscle cells [97]. The underlying mechanisms of cholesterol 
regulation of Cav1.2 channels are, however, poorly understood. To investigate possible effects 
by which cholesterol influences Cav1.2 channels we use MD simulations with different lipid 
compositions.  
Methods. 
All simulations were performed with Gromacs software version 4.0.7 [98] using the 43a1 
force-field [99]. Both closed and open channels were embedded in a 1-palmitoyl-2-oeleoyl 
phosphatidylcholine (POPC) and POPC/CHOL lipid bilayer (Fig. 1). The structure model of the 
closed channel was generated using Modeller 9v7 [63]. The crystal structures of the potassium 
channels KcsA (PDB:1K4C) [86], MlotiK channel (PDB:3BEH) [100], the nonselective cation 
channel NaK (PDB:2AHZ) [88] and a homology model of the NaChBac sodium channel [101] 
served as templates. The closed model was developed using similar procedures as described 
previously [95]. The P-helices and selectivity filter are based on the NaChBac homology model 
only, while the L4-5, S5 and S6 segments are based on all templates. 
The structure of the open conformation was taken from Stary et al. [102]. The P-helix of 
domain III was slightly modified to increase hydrogen bonding between polar side chains. The 
starting configuration of a 128-lipid POPC bilayer was obtained from the end of a 1.6 ns 
simulation preformed by Kandt el at. (http://www.moose.bio.ucalgary.ca) and replicated four 
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times to create a bilayer of 512 lipids. The INFLATEGRO [103] tool was used to embed the 
channels in a POPC lipid bilayer. The POPC/CHOL lipid bilayer was generated by the following 
procedure: A cylindrical hole was introduced to implant the protein by removing a minimal 
number of overlapping POPC/CHOL lipids and compressing the bilayer using Gromacs tools. 
The system was solvated with around 25,339 SPC waters and included 0.1 mol/liter 
concentration of sodium chloride (NaCl).  5 Ca2+ ions were placed along the pore. 
The final POPC systems contained  502 POPC and 147 NaCl molecules. There were 537 
POPC, 176 CHOL and  135 NaCl molecules in the closed channel POPC/CHOL system.  The 
open channel POPC/CHOL system contained 525 POPC, 176 CHOL and 115 NaCl molecules. 
Na+ ions were added randomly within the solvent to neutralize the systems. Thus, there were 11 
and 7 Na+ ion in the closed and open channels, respectively. 
Snapshots of the trajectory were written out every 20 ps. The system was energy minimized with 
the steepest descent algorithm, followed by positional restrained MD for 2 ns. Subsequently, 10 
ns of unrestrained MD simulation were carried out using the NPT ensemble. All simulations 
were repeated 5 times. The Nose-Hoover thermostat [104] with a coupling constant of 0.1 ps to a 
temperature bath of 300 K was used. Pressure was held constant using a semi-isotropic 
Parrinello-Rahman barostat algorithm [105] with a coupling constant of 1 ps. Electrostatic 
interactions were calculated explicitly at a distance smaller than 1 nm, and long-range 
electrostatic interactions were calculated at every step by particle-mesh Ewald summation [106]. 
Lennard-Jones interactions were calculated with a cutoff of 1 nm. Bond lengths were constrained 
using the LINCS algorithm Lennard-Jones interactions were calculated with a cutoff of 1 nm. 
Bond lengths were constrained using the LINCS algorithm [107]. Subsequent analyses of the 
MD simulation data were performed using tools available within GROMACS. 
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Fig.  1.  A snapshot of the channel in the POPC/CHOL bilayer. The helices from domain I and   
III are represented as blue ribbons. POPC and CHOL are shown in gray and yellow. The oxygen 
atoms and hydrogen atoms of the water molecules are shown in white and red, repectively. 
Calcium and NaCl ions are shown as pink and green spheres. 
 
Results 
Stability of system 
 
Fig. 2. (a) Average RMSD values of the backbone and (b) lateral area in closed and open 
channels in POPC and POPC/CHOL systems.   
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The stability of each simulation system is analysed by the root-mean-square displacement 
(RMSD) of the protein backbone atoms. The backbone RMSD of both closed and open channels 
in POPC and POPC/CHOL systems over 10 ns is shown in Fig. 3A.  For the first 3 ns, the 
RMSD value steadily increases and then reaches a plateau. After 3 ns, the RMSD of the closed 
channel in the POPC/CHOL system stabilizes at approximately 0.4 Å.  The RMSD of closed and 
open channels in POPC and the open channel in the POPC/CHOL bilayer are around 0.3 Å. The 
RMSD value of the closed channel in POPC/CHOL is relatively high compared to the other 
systems suggesting a conformational change. To investigate this in more details, decomposition 
of the backbone RMSD values into contributions from different helices is performed as shown in 
Fig 3. It turned out that the loop connecting helix S5 with the P-helix is mainly responsible for 
the increased RMSD values. 
To further analyse the stability of the system we examined the lateral area of the whole 
system as a function of time (Fig. 2B). In the pure POPC systems with closed and open channels, 
the lateral area value decreased to around 180 nm2 and stabilized within 8 ns. Upon addition of 
cholesterol to the POPC bilayer, the area remains stable during the whole simulation at around 
200 and 195 nm2 for closed and open channels. RMSD and the lateral area values confirm that 10 
ns simulation is sufficient for stabilizing the system. 
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Fig. 3. (a) The RMSD from each P helices backbone in closed channel in POPC/CHOL systems 
(b) The RMSF for the P-helix domain III of closed in POPC and POPC/CHOL system (c) The 
RMSF for the P-helix domain IV of closed in POPC and POPC/CHOL system. 
 
 
 
 
 
 
 
 92 
 
Dynamics of Ca2+ in different lipid compositions 
 
 
Fig. 4. Radial distribution functions between (a) whole protein atoms and POPC. (b) whole 
protein atoms and CHOL.  
The selectivity filter in calcium channels is formed by side chains of highly conserved 
glutamates in homologous positions in all four domains, also referred to as EEEE locus  [107] 
(Fig. 5).  
The Ca2+ ion movements from the center of the selectivity filter are analysed using mean 
square displacements (MSD). Ca2+ ions along the pore separate into 2 dynamical groups – fast 
and slow. Simulations show that the Ca2+ ions in the slow group remain at the EEEE locus 
during the whole simulation, while the fast group moves around in the water layer (Fig. 6). 
The slow group MSDs in both closed and open channels in pure POPC have larger values 
compared to simulations containing CHOL. The Ca2+ ions of the slow POPC group are in the 
range of 0 to 5  nm2  for closed and open channels. In the POPC/CHOL system, the MSD values 
were reduced to 0 to 0.2 nm2 for the closed channel and to 0 to 1.6 nm2 for the open channel. Fig. 
6 shows that the Ca2+ ion movement is decreased in both POPC/CHOL systems. This clearly 
shows that cholesterol modulates Ca2+ movement within the channel.  
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Fig. 5. Location of the calcium ions around the selectivity filter. P-helices and S6 domains I and 
III are shown as blue and green ribbons, respectively. Domain IV is colored gray. Glutamates of 
domains I, III and IV are shown as sticks. Domain II is removed for clarity. Slow and fast 
moving Ca2+ ions around the selectivity filter are shown as pink and yellow spheres.  
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Fig. 6. The MSD of Ca2+ ions from the center of mass of the selectivity filter consists of 2 
groups. slow group (a) closed in POPC system (b) closed in  POPC/CHOL system (c) open in 
POPC system (d) open in POPC/CHOL system. For fast group of (e) closed and open in POPC 
and POPC/CHOL systems. 
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Bilayer Fluidity  
 
Fig. 7. The order parameter profile of hydrocarbon tails for the POPC system. 
The order parameter (Scd) as a function of carbon atom number along the hydrocarbon 
tails is shown in Fig. 7. The order parameter values for POPC lipids within 1 nm around the 
closed and open channels are calculated. The values decrease in the order from open channel in 
POPC/CHOL > open channel in POPC > closed channel in POPC/CHOL > closed channel in 
POPC. It is interesting to note that the POPC lipid tail in the open channel shows higher Scd 
values than the closed channel in both systems indicating that the protein has an influence on 
lipid conformation in its neighborhood. This has been seen in other simulations of lipid protein 
interaction as well [108]. Fig. 7 gives a comparison of the order parameter of each system. It is 
obvious that the lipids in the POPC/CHOL system are more ordered than the lipids of the pure 
POPC system. Hence, addition of cholesterol increases lipid packing. This has been found 
experimentally [109] as well as in simulation [110]. 
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Fig. 8. MSD of POPC surrounding the protein  <  and > than 1 nm (a) closed in POPC system (b) 
closed in POPC/CHOL system (c) open in  POPC system (d) open in POPC/CHOL system.  
The mobility of the lipids as a function of distance from the protein, i.e. lipids with < 1nm 
(inner shell) and > 1nm (outer shell) of the protein are displayed in Fig. 8. The MSD values 
reveal details about the movement of POPC. Significant differences are observed between the 
inner and outer shell in the POPC systems but not in the POPC/CHOL systems. There the MSD 
values indicate that POPC movement is homogeneous in the whole bilayer. Fig. 8, A and B show 
that lipids in pure POPC systems which are more than 1 nm away from the protein are faster than 
lipids within 1 nm.  This clearly indicates a binding or at least dynamic coupling between the 
protein and the surrounding lipids. On the other hand, for the POPC/CHOL system such a 
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dynamical difference is not found. This implies that cholesterol plays a crucial rule in restricting 
the lipid movement around 1 nm of POPC.   
 
 
 
Fig. 9. Density profiles for the (a) closed channel in POPC system (b) closed channel in 
POPC/CHOL system (c) open channel in POPC system (d) open channel in POPC/CHOL 
system. 
The density profiles of POPC and POPC/CHOL systems with the protein are plotted in 
Fig. 9 which shows that most of the protein resides within the hydrophobic region of the bilayer. 
Its density is asymmetric between the two leaflets. The salt ions Na+ and Cl-  are mainly located 
in the water and some ions in the head group of POPC. The thickness of the bilayer can be 
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defined as the distance between the phosphorus atom density profile peaks of the two leaflets. 
Fig. 9 shows that the bilayer thickness is 3.8 nm for closed and open channels in pure POPC and 
4.4 nm for closed and open channels in the POPC/CHOL system. It is also noticed that the 
addition of CHOL increases the thickness of the bilayer in agreement with earlier studies [111] 
in POPC whereas the channel protein has no such effect. 
 
Conclusions  
In this study, we examined the effects of different lipid compositions (POPC vs. 
POPC/CHOL) on open and closed Cav1.2 channel structure models. 
The interactions between Cav1.2 open and closed conformations with pure POPC and 
POPC cholesterol mixtures are shown in Fig. 4. It can be seen that cholesterol is not 
preferentially interacting with the closed channel and only a slight interaction with the open 
channel can be observed.  
To determine the dynamics of calcium ions when cholesterol is added to the lipid 
composition, we calculated the average distance of each calcium along the pore from the center 
of mass of selectivity filter travel during the simulation time. It appears that cholesterol 
decreased Ca2+ ion mobility in POPC/CHOL systems in both closed and open Cav1.2 channels. 
This indicates that cholesterol modulates the Ca2+ ion movement. 
The lipid order parameters demonstrate the bilayer fluidity. The open channels in POPC 
and POPC/CHOL have order parameter values higher than the closed channels with both lipid 
compositions. Furthermore, POPC lipids around 1 nm in POPC/CHOL systems (closed and open 
conformation) are more ordered than the lipids in the POPC system. These results show that 
cholesterol has an ordering effect on the POPC lipid tail. Additionally, we investigated the 
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mobility of POPC calculating the MSD values of POPC, where the POPC lipids were classified 
into 2 groups, for lipids whose distance < 1 nm and > 1nm from the protein. Fig. 8 shows 
different lipid behavior for POPC systems vs. POPC/CHOL systems. 
Cholesterol plays a crucial role in restricting the lipid around 1 nm of protein. Thus, our 
simulation demonstrates effects of cholesterol addition to POPC bilayers. It decreases the bilayer 
fluidity and increases the thickness of the bilayer. 
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3.10 Molecular Dynamics studies of the pore region of the newest model Cav1.2 based on 
Voltage-gated sodium (NavAb) channels as a template  
 
  The weak point of the Cav1.2 homology modeling is the lack of the conserved residues at 
the selectivity filter P region between potassium and calcium channel. On June 2011, a new 
voltage-gated sodium channel was published [112] which shares the same highly conserved 
motif with the calcium channel. Based on these studies, a new homology model of Cav1.2 was 
built. The newest homology model was set in the POPC and POPC/CHOL system to focus on 
the effect of the cholesterol of interaction influence with Cav1.2 channel (see manuscript 1). The 
results show in this manuscript is the preliminary data. The part of cholesterol access to the 
channel is in progress.  
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 Abstract 
Increased cholesterol levels are associated with multiple pathological conditions. Here, 
Molecular Dynamics simulations are applied to explain the influence of membrane cholesterol 
levels on voltage-gated calcium channels. We used different lipid compositions to obtain 
information about the possible effects by which cholesterol influences Cav1.2 channels. 
Cholesterol is directly interacting with the protein in the open or the closed conformation. 
Cholesterol is preferentially interacting and penetrates to both channels conformation. 
Cholesterol increases lipid packing implying that it plays a crucial rule in restricting lipid 
movement in the region around 1 nm of POPC. This leads to a direct modulation of Cav1.2 
channel function.  
 
Introduction 
Cholesterol, a major lipid component of the plasma membrane in mammalian cells, is 
essential for normal cell function and growth. Normal cholesterol levels are in the range of 10 – 
45 mol% with respect to other lipids. High cholesterol levels in humans, termed 
hypercholesterolemia, are associated with multiple pathological conditions [1], including 
cardiovascular disease such as stroke and coronary heart disease. Cholesterol blood levels are 
influenced by genetic factors and nutrition. Long term hypercholesterolemia can result in 
disorders such as diabetes mellitus and underactive thyroid. Diet induced hypercholesterolemia 
has been shown to alter the activity of several ion channels and pumps, including voltage-gated 
potassium and calcium channels. For example, Bowles et al, 2004 [2] demonstrated a direct link 
between increased membrane free cholesterol levels and voltage-gated calcium current decrease 
in coronary arterial smooth muscle cells.  
Over the years members of all major ion channel families have been shown to be 
regulated by the level of membrane cholesterol [3]. These include different types of K+ channels 
[4-9], Ca+2 channels [2, 10-13], Na+ channels [14, 15], and Cl− channels [16, 17]. Cholesterol 
effects include suppression of channel activity an effect that was seen in inwardly-rectifying K+ 
channels, voltage gated K+ channels as well as voltage gated Na+ and Ca2+ channels. Other 
channels such as epithelial amiloride-sensitive Na+ channels or TRP (transient receptor 
potential) channels are inhibited by cholesterol depletion.  
The specific mechanisms by which cholesterol modulates ion channel activity are not 
well understood. The regulation of ion channels by cholesterol might occur either via direct 
interaction or via indirect mechanisms. Three different mechanisms of channel regulation have 
been suggested [18, 19]: specific interactions of cholesterol with the channel protein, changes of 
the physical properties of the membrane bilayer (i.e. fluidity) and importance of cholesterol for 
maintaining the scaffolds for protein-protein interactions (“lipid-rafts”). 
Studies by Singh et al [20] suggest that elevated membrane cholesterol levels might 
directly inhibit KirBac1.1 currents. This hypothesis is supported by the fact that these channels 
are sensitive to the chiral nature of cholesterol. In contrast, volume-regulated anion channels 
(VRAC) have been shown to be insensitive to the chirality of cholesterol, suggesting an indirect 
effect, possibly via changes of physical membrane properties such as fluidity and lipid packing 
[16]. 
A growing number of studies on different ion channels indicate that the influence of 
cholesterol is highly heterogeneous [3, 21, 22]. With the recent successes in X-ray crystallization 
of a number of K+ and Na+-channels, a detailed structural analysis investigating the mechanism 
of cholesterol channel interaction becomes possible.  
 Even though, calcium channel crystal structures are not yet available, the recently solved 
X-ray structure of NavAb [23] provides a good template for structure modelling. In analogy to 
voltage-gated potassium and sodium channels, it is assumed that helices L4-5, S5 and S6, the P-
helices and the loops connecting them, form a selective pore for ion conduction (Fig. 1). 
Numerous homology models of Cav channels based on K+ channel templates have been 
successfully used to explain experimental data and suggest new experiments (Zhorov, Lipkind, 
Fozzard, Stary etc) [24-28]. However, to our knowledge this is the first study reporting on a 
Cav1.2 model based on the more closely related NavAb sodium channel structure. This template 
is especially advantageous for modelling the selectivity filter region and P-helices, since there is 
high sequence similarity in these regions and for both channel type side chains in the selectivity 
filter are assumed to participate in conductance. 
In the present study, we focus on how cholesterol interacts with a closed Cav1.2 channels 
model, by applying Molecular Dynamics simulations. Our results provide strong evidence for a 
direct modulation of Cav1.2 channels by membrane cholesterol. 
 
Methods 
Simulation Setup 
All simulations were performed with Gromacs software version 4.0.7 [29] using the 43a1 
force-field [30]. The pore region of Cav1.2 channel was embedded in a 1-palmitoyl-2-oeleoyl 
phosphatidylcholine (POPC) and POPC/CHOL lipid bilayer (Fig. 2). The structure model of 
Cav1.2 pore region channel was generated using Modeller 9v7 [31]. The crystal structures of the 
NavAb voltage-gated sodium channel (PDB: 3RVY) [23] served as templates.  
The starting configuration of a 128-lipid POPC bilayer was obtained from the end of a 1.6 
ns simulation preformed by Kandt el at. (http://www.moose.bio.ucalgary.ca) and replicated four 
times to create a bilayer of 512 lipids. The POPC/CHOL lipid bilayer was generated by the 
starting configuration of 260-single POPC bilayer and 65-single CHOL to create a monolayer 
and replicated 2 times to create a 520 POPC and 130 CHOL bilayer. The Gromacs tools were 
used to embed and compressing the channels in a POPC and POPC/CHOL lipid bilayer. The 
systems were solvated with around 25,339 SPC waters and included 0.1 mol/liter concentration 
of sodium chloride (NaCl).  9 Ca2+ ions were placed randomly along the pore. 
The three systems of the Cav1.2 pore region in POPC and POPC/CHOL environment 
were performed by vary the starting position of Ca2+ along the pore. As same as, three systems of 
the Cav1.2 pore region in POPC/CHOL environment were generated by add the starting position 
of Ca2+ along the pore and CHOL randomly. The final POPC system contains 502 POPC and 
147 NaCl molecules. For POPC/CHOL system, there were 501 POPC and 130 CHOL in the first 
system, 490 POPC and 130 CHOL in the second system and 498 POPC and 129 CHOL in the 
third system. Cl- ions were added randomly within the solvent to neutralize the systems. Thus, 
there were 9 Cl-   ions in the channels. 
Snapshots of the trajectory were written out every 20 ps. The system was energy 
minimized with the steepest descent algorithm, followed by positional restrained MD for 2 ns. 
Subsequently, 50 ns of unrestrained MD simulation were carried out using the NPT ensemble. 
The Nose-Hoover thermostat [32] with a coupling constant of 0.1 ps to a temperature bath of 300 
K was used. Pressure was held constant using a semi-isotropic Parrinello-Rahman barostat 
algorithm [33] with a coupling constant of 1 ps. Electrostatic interactions were calculated 
explicitly at a distance smaller than 1 nm, and long-range electrostatic interactions were 
calculated at every step by particle-mesh Ewald summation [34]. Lennard-Jones interactions 
were calculated with a cutoff of 1 nm. Bond lengths were constrained using the LINCS algorithm 
[35]. Subsequent analyses of the MD simulation data were performed using tools available 
within GROMACS. 
 
Umbrella Sampling Simulations. 
 Staring structure of the umbrella simulation of cholesterol pulling through the Cav1.2 
pore region channel was taken from the snapshots of equilibration simulation for Cav1.2 in 
POPC/CHOL system. Potential of mean force (PMF) was performed by one dimensional 
umbrella sampling. The 32 positions were selected in range 3.5 – 5.0 nm. Adjacent umbrella 
windows were separated by 0.25 nm.  Each window was simulated for 5 ns. The reaction 
coordinate for cholesterol permeation is the y-axis along the distance of the center of mass of 
pulling cholesterol and reference cholesterol molecule at a pull rate of 0.2 Å/ps. During 
simulation, the probing cholestoral was restrained harmonically with a 1000 kJ/mol/nm2 force 
constant in the y-axis. 
 
Results 
 Cholesterol is known to influence different type of ion channel. The underlying 
mechanisms of cholesterol regulation of Cav1.2 channels are, however, poorly understood. To 
investigate possible effects by which cholesterol influences Cav1.2 channels we use MD 
simulations with different lipid compositions.  
 
 
Stability of system 
 
Fig 3 
 
The stability of each simulation system is analysed by the root-mean-square displacement 
(RMSD) of the protein backbone atoms. The backbone RMSD of channels in POPC and 
POPC/CHOL systems over 50 ns is shown in Fig. 3A and 3B.  For the first 30 ns, the RMSD 
value steadily increases and then reaches a plateau. After 30 ns, the RMSD of each simulation of 
the Cav1.2 channel in the POPC system stabilizes at approximately 0.350, 0.30 and 0.325 Å.  
The RMSD of each simulation of the Cav1.2 channels in POPC/CHOL bilayer are around 0.3 Å.  
To further analyse the stability of the system we examined the lateral area of the whole 
system as a function of time (Fig. 4A and 4B). In the pure POPC systems of Cav1.2 channels, the 
lateral area value decreased to around 170 nm2 and stabilized within 30 ns. Upon addition of 
cholesterol to the POPC bilayer, the area remains stable during the whole simulation at around 
175 nm2. RMSD and the lateral area values confirm that 50 ns simulation is sufficient for 
stabilizing the system. 
 
Fig 4 
 
 
 
 
 
Bilayer Fluidity  
 
Fig 5 
 
The order parameter (Scd) as a function of carbon atom number along the hydrocarbon 
tails is shown in Fig. 5. The order parameter values for POPC lipids within 1 nm around the 
channels are calculated. It is interesting to note that the POPC/CHOL lipid tail in the channel 
shows higher Scd values than the channel in POPC indicating that the protein has an influence on 
lipid conformation in its neighborhood. This has been seen in other simulations of lipid protein 
interaction as well [36]. Fig. 5 gives a comparison of the order parameter of each system. It is 
obvious that the lipids in the POPC/CHOL system are more ordered than the lipids of the pure 
POPC system. Hence, addition of cholesterol increases lipid packing. This has been found 
experimentally [37] as well as in simulation [38].  
 
Fig 6,7 
 
The mobility of the lipids as a function of distance from the protein, i.e. lipids with < 1nm 
(inner shell) and > 1nm (outer shell) of the protein are displayed in Fig. 6 and 7. The MSD 
values reveal details about the movement of POPC. Significant differences are observed between 
the inner and outer shell in the POPC systems but not in the POPC/CHOL systems. There the 
MSD values indicate that POPC movement is homogeneous in the whole bilayer. Fig. 6, A to C 
shows that lipids in pure POPC systems which are more than 1 nm away from the protein are 
faster than lipids within 1 nm.  This clearly indicates a binding or at least dynamic coupling 
between the protein and the surrounding lipids. On the other hand, for the POPC/CHOL system 
such a dynamical difference is not found. This implies that cholesterol plays a crucial rule in 
restricting the lipid movement around 1 nm of POPC.   
 
Fig 8 
 
The density profiles of POPC and POPC/CHOL systems with the protein are plotted in 
Fig. 8 which shows that most of the protein resides within the hydrophobic region of the bilayer. 
Its density is asymmetric between the two leaflets. The salt ions Na+ and Cl-   are mainly located 
in the water and some ions in the head group of POPC. The thickness of the bilayer can be 
defined as the distance between the phosphorus atom density profile peaks of the two leaflets. 
Fig. 8A to C shows that the bilayer thickness is 4.0 nm for channels in pure POPC and 4.2 nm 
for channels in the POPC/CHOL system. It is also noticed that the addition of CHOL increases 
the thickness of the bilayer in agreement with earlier studies [39] in POPC whereas the channel 
protein has no such effect. 
 
Dynamics of cholesterol  
Fig 9 
 
To determine the interaction between protein and POPC or cholesterol (CHOL) radial 
distribution functions (RDF) were calculated. The radial distribution function of POPC around 
the center of mass of protein of all 3 simulations reveals three peaks (Fig. 9A). The first peak 
occurs at around 3.0 nm. The following peaks are approximately at 3.5 and 4.0 nm. This 
indicates increased probability to find POPC molecules in the direct neighborhood of the entire 
region around the protein, which is around 3.0 nm (first solvation shell), 3.5 nm and 4.0 nm. Fig. 
9B to 9C shows the RDF between the center of mass of the protein with POPC and CHOL of 
each run in POPC/CHOL system. All 3 simulations of channel in POPC/CHOL demonstrate that 
the first peak of POPC is around 3.0 nm while there are several peaks of CHOL occur between 
0.4 to 3.0 nm. These imply that cholesterol is preferentially interacting and penetrate to the 
channel as shown in Fig 10b.   
 
Direction of cholesterol access to Cav1.2 pore channel. 
 From our 3 runs of free MD, we found from 2 of 3 simulations that the head of 
cholesterol enter predominantly between these S6 of domain I and IV helices. Then, our PMFs 
are focused on this region only. 
 
Fig10, 11 
 
The potentials of mean force (PMFs) are used to characterize the energies of the pulling 
cholesterol. The pulling cholesterol was pulled in between domain I and IV to the cavity of 
Cav1.2 (Fig 10). The PMFs for pulling cholesterol across the y-axis is displayed in Fig 11. The 
PMFs value between 3.5 – 4.0 nm which is the interface of S6 domain I and IV region decrease. 
After 4.0 nm which is the cavity of Cav1.2 region, the barrier values are steadily increases. It is 
implied that cholesterol prefer to locate at the interface region of S6 domain I and IV, due to the 
hydrophobic residue ( Phe, Ile, Val, Leu) at the interface interact with cholesterol. The most 
favorable position of cholesterol is at 4 nm which is the lowest PMFs value. At the cavity of 
Cav1.2 which is hydrophilic region, cholesterol is less prefers to locate in this area. 
 
Conclusions  
In this study, we examined the effects of different lipid compositions (POPC vs. 
POPC/CHOL) on Cav1.2 channel structure models. 
The lipid order parameters demonstrate the bilayer fluditity. The channels in 
POPC/CHOL have order parameter values higher than channels in pure POPC compositions. 
Furthermore, POPC lipids around 1 nm in POPC/CHOL systems are more ordered than the lipids 
in the POPC system. These results show that cholesterol has an ordering effect on the POPC 
lipid tail. Additionally, we investigated the mobility of POPC calculating the MSD values of 
POPC, where the POPC lipids were classified into 2 groups, for lipids whose distance < 1 nm 
and > 1nm from the protein. Fig. 6 and 7 shows different lipid behavior for POPC systems vs. 
POPC/CHOL systems. 
Cholesterol plays a crucial role in restricting the lipid around 1 nm of protein. Thus, our 
simulation demonstrates effects of cholesterol addition to POPC bilayers. It decreases the bilayer 
fluiditity and increases the thickness of the bilayer. The interactions between Cav1.2 with pure 
POPC and POPC cholesterol mixtures are shown in Fig. 8.  
A remarkable feature, only seen in a handful of ion channels (including TWIK, TRAAK 
and NavAb) are lateral pore openings below the selectivity filter, leading from the lumen of the 
pore to the membrane. It can be seen that cholesterol is directly interacting and penetrating to the 
side open of channel (Fig. 9). The predomination enter of head of cholesterol access to Cav1.2 is 
the region between domain I and IV (Fig 10).   
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Figure legends 
Fig. 1. Structure details of the Cav1.2 pore region, which is composed of linker L45 , helices S5 
and S6 from four domains. The helices from domains I and III are shown in gray. The helices of 
domains II and IV are colored: orange (L45), red (S5), green (P) and blue (S6).  
Fig.  2.  A snapshot of the channel in the POPC/CHOL bilayer. The helices from domain I to    
III are represented as orange, white and violet surface. POPC and CHOL are shown in blue and 
yellow. The oxygen atoms and hydrogen atoms of the water molecules are shown in white and 
red, respectively. Calcium and NaCl ions are shown as red and green spheres. 
Fig. 3. (a) Average RMSD values of the backbone of channel in POPC system (b) Average 
RMSD values of the backbone of channel in POPC/CHOL systems.  
Fig. 4. (a) Lateral area of channels in POPC and (b) POPC/CHOL systems.   
Fig. 5. The order parameter profile of hydrocarbon tails for the POPC and POPC/CHOL system. 
Fig. 6. MSD of POPC surrounding the protein < and > than 1 nm in POPC (a) 1st run (b) 2nd run 
(c) 3rd run.  
Fig. 7. MSD of POPC surrounding the protein < and > than 1 nm in POPC/CHOL (a) 1st run (b) 
2nd run (c) 3rd run.  
Fig. 8. Density profiles for the (a) 1st run in POPC (b) 2nd run in POPC (c) 3rd run in POPC (d) 1st 
run in POPC/CHOL (e) 2nd run in POPC/CHOL (f) 3rd run in POPC.  
Fig. 9. Radial distribution functions between (a) 3 different run of center of mass of protein 
atoms and POPC in POPC system. (b) center of mass of protein atoms with POPC and CHOL of   
1st run in POPC/CHOL (c) center of mass of protein atoms with POPC and CHOL of   2nd  run in 
POPC/CHOL (d) b) center of mass of protein atoms with POPC and CHOL of   3rd run in 
POPC/CHOL. 
Fig. 10. Direction of cholesterol access to Cav1.2. Domain I and IV of Cav1.2 are represented as 
orange and pink ribbon. Domain II and II are shown in grey. (a) top view show cholesterol 
before access to the Cav1.2 (b) top view show cholesterol locate at the interface of domain I and 
IV of Cav1.2 . (c) side view show cholesterol before access to the Cav1.2 (d) side view show 
cholesterol when access into the interface of domain I and IV of Cav1.2. 
Fig. 11.  A. the PMFs of pulling cholesterol permeation across the Cav1.2 pore region B. a 
snapshot of cholesterol which penetrates to the channel. The Cav1.2 pore region is represented as 
grey ribbon. The pulling cholesterol is shown in green. The oxygen atoms and hydrogen atoms 
of the water molecules are shown in white and red, respectively. The POPC and cholesterol in 
POPC are shown as blue and yellow, respectively. 
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3.11 Comparison between the closed conformation models of Cav1.2 based on Voltage-
gated potassium (KcsA) and Voltage-gated sodium (NavAb) channel 
 In our work, two closed conformations of Cav1.2 were built and used to investigate the 
structure and dynamics. The first model was built based on the voltage-gated potassium (KcsA) 
and the second model build based on the new Voltage-gated sodium (NavAb) channel structure. 
The global architecture of these two models is almost similar as seen from the top (Fig 3.25 a) 
and side (Fig 3.25 b) view, respectively. The root mean square displacement (RMSD) of the 
backbone atoms of these two models is 1.9 Å which is remarkable similar.  
 
    
(a) (b) 
(b)  
Fig 3.25. The superposition of the Cav1.2 based on Voltage-gated potassium (KcsA) and 
Voltage-gated sodium (NavAb) are colored in yellow and pink, respectively.  (a) Top view detail 
of pore domain (b) Side view detail of pore domain. 
 
The main difference of these two models is at the P-linker. As shown in Fig 3.26 a, the 
tilt of these two models at selectivity filter is different. Fig 3.26 b show that P-helix in the Cav1.2 
model based on Voltage-gated potassium (KcsA) are tilt closed to binding residue Y1490 which 
prevents optimal interactions.  
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(a)            (b) 
 
Fig 3.26.  The superimposition of the Cav1.2 pore forming subunits based on Voltage-gated 
potassium (KcsA) and Voltage-gated sodium (NavAb) are colored in yellow and pink, 
respectively: shows IVP and IVS6. (b) Details of P-helix and binding residue Y1490.  
 
 Fig 3.27 demonstrate the selectivity filter of both models in more detail showing 
hydrogen bonds between selected residues. As can be seen in Fig. 3.27a and b the selectivity 
filter region, which in the old model (a) was not based on any template is significantly different 
compared to the new model. This is not unexpected, since ab initio homology modeling is still 
rather challenging and the accuracies can vary significantly. The most remarkable difference is in 
the positioning of the highly conserved tryptophan residues, which was assumed to be pore 
facing in the old model. A direct contribution of this residue to ion selectivity has also been 
wrongly proposed by the Zhorov group [113]. 
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(a)            (b) 
 
 
(c) 
 
Fig 3.27. The selectivity filter of (a) Cav1.2 model based on Voltage-gated potassium (KcsA) (b) 
Cav1.2 model based on Voltage-gated sodium (NavAb). The dashed-lines indicate the hydrogen 
bonding (c) The prediction pattern of calcium atom binding in the Cav1.2 proposed by the 
Zhorov Group  
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(a)            (b) 
       
      
(c)            (d) 
 
 
Fig 3.28. (a) Selectivity filter sequence alignment. Glutamic acids homologues in selectivity 
filter are shaded purple; outer ring of negatively charged residues is shaded orange (b) Conserved 
interaction network within the NavAb pore (c) the selectivity filter of backbone and side chain of 
NavAb (d) the Cav1.2 based on Voltage-gated sodium (NavAb). The dashed-lines indicate the 
hydrogen bonding.  
 
Based on the high sequence similarity (see Fig 3.28 a) Payandeh et al, 2011 strongly 
suggests that the architecture of the calcium channel pore might be highly similar to the structure 
observed in NavAb [112]. The NavAb pore architecture (can be seen in Fig 3.28 b), which shows 
important interactions in the selectivity filter region. Interactions within one P-helix and between 
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P-helices are shown. These interaction networks probably play an important role determines the 
stability of the pore and the selectivity filter. Probably the most unexpected feature is the fact 
that not only glutamate side chains line the wall of the selectivity filter, but that backbone 
residues including a highly conserved threonine residue participate in filter formation (Fig 3.28 
c). These hydrogen bond networks are also see in our new Cav1.2 model based on NavAb. Fig 
3.28 d shows that Thr 1143 of DIII interacts with the TRP1448 of DIV. Similar hydrogen bonds 
are also formed between threonine and tryptophane residues from the other domains (not shown). 
These new models also provide a good explanation, why docking studies (see chapters 
3.4) and MD simulations on blockers were only partially successful based on the old models. 
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CHAPTER 4 
SUMMARY 
 
The voltage gated L-type calcium channels Cav1.2 are membrane proteins which are 
important components of living cells. The majority of drugs are targeted to membrane proteins. 
The structure and function of closed and open conformations of voltage gated L-type calcium 
channels Cav 1.2 were studied in the thesis.  The molecular targets of Cav1.2 channels are used 
widely in the therapy of cardiovascular diseases. Due to absence of three dimensional structures, 
the function of these membrane proteins are still not well understood for this channel, therefore 
theoretical methods including sequence alignment, homology modeling, molecular docking and 
molecular dynamic simulation were preformed to investigate this channel in detail.   
The pore region of the closed and the open conformation of Cav1.2 channel models were 
used to address the key questions of the structure and function of this channel. For the closed 
conformation model, eight different models were built based on multiple templates of KcsA, 
MlotiK, nonselective cation channel NaK sodium channel crystal structure and homology model 
of the NaChBac sodium channel. The various quality assessment methods (Prosa2003, Verify 
3D, WHAT_CHECK Packing, Procheck, ProQresLG and ProQres MaxSub) were applied to 
evaluate the quality of the model.  The best ranked structure from the agreement of all programs 
was selected for further work.  For the open conformation model, there are 2 models. 1) The 
Cav1.2 open conformation model is taken from Stary et al, 2009. 2) The Cav1.2 open 
conformation improved model was built by H.R Guy, it was modified and improved from the 
experimental and computational data.  Moreover, Ab Initio method was applied to predict the 
loop structure of calcium channel Cav3.1 combined with the results of experimental 
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investigation. We found that for our work the Ab Initio methods are still not accurate enough to 
observe the various possible disulfide bonds in the model.       
The molecular docking method was used to investigate the ligand interaction with Cav1.2. 
The open conformation model is taken from Stary et al, 2008. As ligands were used on PAA 
verapamil and its derivatives in protonated states of both R and S chirality. The results showed 
that all ligands share similar orientation and position where the ligands are located between IIIS6 
and IVS6. The positively charged nitrogen atoms of all ligands bind to the glutamic acids E1145 
and E1446 due to the electrostatic interactions. We found that Cav1.2 in the open conformation 
model with verapamil and its derivatives obtained from molecular docking is somehow in 
disagreement with experimental data. Then, the Cav1.2 open conformation improved model was 
introduced to be used for further investigation.  
The Molecular dynamics simulations were performed over 50 ns to refine the closed and 
improved open conformation model. These simulations show that the closed and improved open 
conformations are stable. Consequently, the molecular docking of improved open model with 
various ligand were performed again. The good pose docking structures of each ligand were 
selected to set the MD simulation.  
The MD simulation of the improved open conformation with verapamil, and quaternary 
(-) diltiazem were carried out for 20 and 40 ns to check the stability of the complex and examine 
conformational variations of ligands. The results from MD simulation of verapamil and 
quaternary (-) diltiazem complex demonstrate that the complexes are stable and in good 
agreement with published values for low sequence identity homology models. In addition, five 
different starting orientations of the D619 and two different starting orientations of the T13 were 
performed for simulation. Simulations show that those complexes remain stable after 15 ns. The 
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benzene ring, the ammonium group and the nitrile group are rather rigid, the hydrogen and 
fluorine atoms are fluctuation to some extent. For D619, the benzene ring faces to one of IIIS6 or 
IVS6. In case of T13, benzene ring of the hydrogen binds to each domain IIIS6 and IVS6. 
However, these simulations of D619 and T13 complexes are a preliminary study. Thus, more 
experimental data are needed for further studies.  
 Another focus of this thesis concerned the effect of cholesterol influencing Cav1.2 
channels in both closed and open conformation. Both closed and improved open channels were 
taken and embedded into POPC and POPC/CHOL lipid bilayer. MD simulation methods are 
applied in this work.  In the POPC system of both models, the movement of the outer shell ( > 
1nm) is faster than that of the inner shell ( < 1 nm ). For POPC/CHOL system of both models 
there no movement difference could be observed. In term of bilayer fluidity, the lipid order 
parameters demonstrate that order parameter values of both models in POPC/CHOL system are 
higher than in the POPC system. The density profiles notice that the bilayer thickness of both 
models in POPC/CHOL system is higher than in the POPC system. It is implies that the addition 
of CHOL decreases the bilayer fluidity and increases the thickness of the bilayer.  
 Due to the weak point of the first homology modeling of Cav1.2 based on potassium 
channel as a template. On June 2011, a new voltage-gated sodium channel (NavAb) was 
published. NavAb channel shares the same highly sequence identity at the selectivity filter P 
region with Cav1.2. Then, a new homology modeling of Cav1.2 was built and uses to investigate 
the effect of cholesterol influence with Cav1.2 channel. The global architecture of these two 
models is almost similar which the RMSD of the backbone of these two models is only 1.9 Å. 
These two difference models are mainly different at the P-linker. Moreover, MD simulation 
method is used to investigate the effect of cholesterol with new Cav1.2 homology model. New 
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homology model channels were taken and embedded into POPC and POPC/CHOL lipid bilayer. 
The results show that cholesterol plays a crucial role to increase lipid packing and increase the 
thickness of the bilayer. From the RDF of cholesterol and channel, it shows that there are several 
peaks of cholesterol occur inside the Cav1.2. These imply that cholesterol is preferentially 
interacting and penetrate to the Cav1.2. The umbrella sampling method was used in this work 
which focuses in more detail about the access pathway of cholesterol into channel. The potentials 
of mean force demonstrate that the most favorable region of cholesterol interact with Cav1.2 
locate at the interface region of S6 domain I and IV due to the hydrophobic residue on this 
region. At the cavity of Cav1.2 which is hydrophilic region, cholesterol is less prefers to locate in 
this area. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 135 
 
REFERENCE 
 
1. Hedin, L.E., K. Illergard, and A. Elofsson, An introduction to membrane proteins. J 
Proteome Res, 2011. 10(8): p. 3324-31. 
2. Kleinschmidt, J.H., Membrane Proteins – Introduction. Cellular and Molecular Life 
Sciences, 2003. 60(8): p. 1527-1528. 
3. http://www.blanco.biomol.uci.edu/mpstruc/listAll/list. 
4. Ujwal, R. and J.U. Bowie, Crystallizing membrane proteins using lipidic bicelles. 
Methods. 55(4): p. 337-41. 
5. Gourdon, P., et al., HiLiDe-Systematic Approach to Membrane Protein Crystallization in 
Lipid and Detergent. Crystal Growth & Design. 11(6): p. 2098-2106. 
6. Hille, B., Ion Channels of Excitable Membranes, ed. rd. 2001: Sinauer Associates  
7. Bidaud, I., et al., Voltage-gated calcium channels in genetic diseases. Biochim Biophys 
Acta, 2006. 1763(11): p. 1169-74. 
8. Catterall, W.A., et al., International Union of Pharmacology. XLVIII. Nomenclature and 
structure-function relationships of voltage-gated calcium channels. Pharmacol Rev, 
2005. 57(4): p. 411-25. 
9. Stary, A., et al., Structural model of the Ca V 1.2 pore. Channels (Austin), 2008. 2(3): p. 
210-5. 
10. Doyle, D.A., et al., The structure of the potassium channel: molecular basis of K+ 
conduction and selectivity. Science, 1998. 280(5360): p. 69-77. 
11. Kim, M.S., et al., Structural determinants of ion selectivity in brain calcium channel. 
FEBS Lett, 1993. 318(2): p. 145-8. 
 136 
 
12. Tang, S., et al., Molecular localization of ion selectivity sites within the pore of a human 
L-type cardiac calcium channel. J Biol Chem, 1993. 268(18): p. 13026-9. 
13. Yang, J., et al., Molecular determinants of Ca2+ selectivity and ion permeation in L-type 
Ca2+ channels. Nature, 1993. 366(6451): p. 158-61. 
14. Ellinor, P.T., et al., Ca2+ channel selectivity at a single locus for high-affinity Ca2+ 
interactions. Neuron, 1995. 15(5): p. 1121-32. 
15. Van Petegem, F. and D.L. Minor, Jr., The structural biology of voltage-gated calcium 
channel function and regulation. Biochem Soc Trans, 2006. 34(Pt 5): p. 887-93. 
16. Daniel L. Minor, J., An overview of ion channel structure. Handbook of Cell Signaling, 
Three-Volum Set 2 ed., 2010. 
17. Hagiwara, S., S. Ozawa, and O. Sand, Voltage clamp analysis of two inward current 
mechanisms in the egg cell membrane of a starfish. J Gen Physiol, 1975. 65(5): p. 617-
44. 
18. Dolphin, A.C., A short history of voltage-gated calcium channels. Br J Pharmacol, 2006. 
147 Suppl 1: p. S56-62. 
19. Tanabe, T., et al., Primary structure of the receptor for calcium channel blockers from 
skeletal muscle. Nature, 1987. 328(6128): p. 313-8. 
20. Mikami, A., et al., Primary structure and functional expression of the cardiac 
dihydropyridine-sensitive calcium channel. Nature, 1989. 340(6230): p. 230-3. 
21. Biel, M., et al., Primary structure and functional expression of a high voltage activated 
calcium channel from rabbit lung. FEBS Lett, 1990. 269(2): p. 409-12. 
 137 
 
22. Koch, W.J., P.T. Ellinor, and A. Schwartz, cDNA cloning of a dihydropyridine-sensitive 
calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms. 
J Biol Chem, 1990. 265(29): p. 17786-91. 
23. Seino, S., et al., Cloning of the alpha 1 subunit of a voltage-dependent calcium channel 
expressed in pancreatic beta cells. Proc Natl Acad Sci U S A, 1992. 89(2): p. 584-8. 
24. Williams, M.E., et al., Structure and functional expression of alpha 1, alpha 2, and beta 
subunits of a novel human neuronal calcium channel subtype. Neuron, 1992. 8(1): p. 71-
84. 
25. Bech-Hansen, N.T., et al., Loss-of-function mutations in a calcium-channel alpha1-
subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. 
Nat Genet, 1998. 19(3): p. 264-7. 
26. Strom, T.M., et al., An L-type calcium-channel gene mutated in incomplete X-linked 
congenital stationary night blindness. Nat Genet, 1998. 19(3): p. 260-3. 
27. Mori, Y., et al., Primary structure and functional expression from complementary DNA 
of a brain calcium channel. Nature, 1991. 350(6317): p. 398-402. 
28. Horne, W.A., et al., Molecular diversity of Ca2+ channel alpha 1 subunits from the 
marine ray Discopyge ommata. Proc Natl Acad Sci U S A, 1993. 90(9): p. 3787-91. 
29. Williams, M.E., et al., Structure and functional expression of an omega-conotoxin-
sensitive human N-type calcium channel. Science, 1992. 257(5068): p. 389-95. 
30. Soong, T.W., et al., Structure and functional expression of a member of the low voltage-
activated calcium channel family. Science, 1993. 260(5111): p. 1133-6. 
31. Klugbauer, N., et al., A T-type calcium channel from mouse brain. Pflugers Arch, 1999. 
437(5): p. 710-5. 
 138 
 
32. Cribbs, L.L., et al., Cloning and characterization of alpha1H from human heart, a 
member of the T-type Ca2+ channel gene family. Circ Res, 1998. 83(1): p. 103-9. 
33. Lee, A., et al., Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. 
Nature, 1999. 399(6732): p. 155-9. 
34. Lacinova, L., Voltage-dependent calcium channels. Gen Physiol Biophys, 2005. 24 
Suppl 1: p. 1-78. 
35. Lehmann-Horn, F. and K. Jurkat-Rott, Voltage-gated ion channels and hereditary 
disease. Physiol Rev, 1999. 79(4): p. 1317-72. 
36. Hockerman, G.H., et al., Molecular determinants of drug binding and action on L-type 
calcium channels. Annu Rev Pharmacol Toxicol, 1997. 37: p. 361-96. 
37. Benitah, J.P., et al., Voltage-gated Ca2+ currents in the human pathophysiologic heart: a 
review. Basic Res Cardiol, 2002. 97 Suppl 1: p. I11-8. 
38. Hering, S., et al., Ca2+ channel block and inactivation: common molecular determinants. 
Trends Pharmacol Sci, 1998. 19(11): p. 439-43. 
39. Motoike, H.K., et al., A region in IVS5 of the human cardiac L-type calcium channel is 
required for the use-dependent block by phenylalkylamines and benzothiazepines. J Biol 
Chem, 1999. 274(14): p. 9409-20. 
40. Hering, S., et al., Molecular mechanism of use-dependent calcium channel block by 
phenylalkylamines: role of inactivation. Proc Natl Acad Sci U S A, 1997. 94(24): p. 
13323-8. 
41. Hockerman, G.H., et al., Molecular determinants of high affinity phenylalkylamine block 
of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the 
alpha1 subunit. J Biol Chem, 1997. 272(30): p. 18759-65. 
 139 
 
42. Hockerman, G.H., et al., Molecular determinants of high affinity phenylalkylamine block 
of L-type calcium channels. J Biol Chem, 1995. 270(38): p. 22119-22. 
43. Hockerman, G.H., et al., Molecular determinants of diltiazem block in domains IIIS6 and 
IVS6 of L-type Ca(2+) channels. Mol Pharmacol, 2000. 58(6): p. 1264-70. 
44. Hescheler, J., et al., Does the organic calcium channel blocker D600 act from inside or 
outside on the cardiac cell membrane? Pflugers Arch, 1982. 393(4): p. 287-91. 
45. Bayer, R., R. Kaufmann, and R. Mannhold, Inotropic and electrophysiological actions of 
verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the 
optical isomers. Naunyn Schmiedebergs Arch Pharmacol, 1975. 290(1): p. 69-80. 
46. Mannhold, R., et al., Investigations on the structure-activity relationships of verapamil. 
Naunyn Schmiedebergs Arch Pharmacol, 1978. 302(2): p. 217-26. 
47. Spector, A.A. and M.A. Yorek, Membrane lipid composition and cellular function. J 
Lipid Res, 1985. 26(9): p. 1015-35. 
48. Tillman, T.S. and M. Cascio, Effects of membrane lipids on ion channel structure and 
function. Cell Biochem Biophys, 2003. 38(2): p. 161-90. 
49. Rees, D.C., L. DeAntonio, and D. Eisenberg, Hydrophobic organization of membrane 
proteins. Science, 1989. 245(4917): p. 510-3. 
50. Baenziger, J.E., T.E. Darsaut, and M.L. Morris, Internal dynamics of the nicotinic 
acetylcholine receptor in reconstituted membranes. Biochemistry, 1999. 38(16): p. 4905-
11. 
51. Ren, J., et al., Control of the transmembrane orientation and interhelical interactions 
within membranes by hydrophobic helix length. Biochemistry, 1999. 38(18): p. 5905-12. 
 140 
 
52. Ren, J., et al., Transmembrane orientation of hydrophobic alpha-helices is regulated both 
by the relationship of helix length to bilayer thickness and by the cholesterol 
concentration. Biochemistry, 1997. 36(33): p. 10213-20. 
53. Mall, S., et al., Effects of aromatic residues at the ends of transmembrane alpha-helices 
on helix interactions with lipid bilayers. Biochemistry, 2000. 39(8): p. 2071-8. 
54. de Meyer, F. and B. Smit, Effect of cholesterol on the structure of a phospholipid bilayer. 
Proc Natl Acad Sci U S A, 2009. 106(10): p. 3654-8. 
55. Levitan, I., et al., Cholesterol and ion channels. Subcell Biochem, 2010. 51: p. 509-49. 
56. Barrantes, F.J., Structural basis for lipid modulation of nicotinic acetylcholine receptor 
function. Brain Res Brain Res Rev, 2004. 47(1-3): p. 71-95. 
57. Lundbaek, J.A. and O.S. Andersen, Spring constants for channel-induced lipid bilayer 
deformations. Estimates using gramicidin channels. Biophys J, 1999. 76(2): p. 889-95. 
58. Xu, D., Y. Xu, and E.C. Uberbacher, Computational tools for protein modeling. Curr 
Protein Pept Sci, 2000. 1(1): p. 1-21. 
59. Boeckmann, B., et al., The SWISS-PROT protein knowledgebase and its supplement 
TrEMBL in 2003. Nucleic Acids Res, 2003. 31(1): p. 365-70. 
60. Altschul, S.F., et al., Gapped BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nucleic Acids Res, 1997. 25(17): p. 3389-402. 
61. Chenna, R., et al., Multiple sequence alignment with the Clustal series of programs. 
Nucleic Acids Res, 2003. 31(13): p. 3497-500. 
62. Eswar, N., et al., Comparative protein structure modeling using Modeller. Curr Protoc 
Bioinformatics, 2006. Chapter 5: p. Unit 5 6. 
 141 
 
63. Sali, A. and T.L. Blundell, Comparative protein modelling by satisfaction of spatial 
restraints. J Mol Biol, 1993. 234(3): p. 779-815. 
64. Wiederstein, M. and M.J. Sippl, ProSA-web: interactive web service for the recognition 
of errors in three-dimensional structures of proteins. Nucleic Acids Res, 2007. 35(Web 
Server issue): p. W407-10. 
65. Bowie, J.U., R. Luthy, and D. Eisenberg, A method to identify protein sequences that fold 
into a known three-dimensional structure. Science, 1991. 253(5016): p. 164-70. 
66. Hooft, R.W., et al., Errors in protein structures. Nature, 1996. 381(6580): p. 272. 
67. Laskowski, R.A., et al., PROCHECK: a program to check the stereochemical quality of 
protein structures. Journal of Applied Crystallography, 1993. 26(2): p. 283-291. 
68. Kim, D.E., D. Chivian, and D. Baker, Protein structure prediction and analysis using the 
Robetta server. Nucleic Acids Research, 2004. 32(suppl 2): p. W526-W531. 
69. Zhang, Y., I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 
2008. 9: p. 40. 
70. Moult, J., et al., A large-scale experiment to assess protein structure prediction methods. 
Proteins, 1995. 23(3): p. ii-v. 
71. http://zhanglab.ccmb.med.umich.edu/I-TASSER/. 
72. Larsson, P., et al., Using multiple templates to improve quality of homology models in 
automated homology modeling. Protein Sci, 2008. 17(6): p. 990-1002. 
73. Saxena, A., et al., The basic concepts of molecular modeling. Methods Enzymol, 2009. 
467: p. 307-34. 
74. Glide. 2008: New york. 
75. MOE, Chemical Computing Group, Inc.: Montreal, Quebec, Canada. 
 142 
 
76. GaussView. 2009., Roy Dennington, Todd Keith and John Millam,Semichem Inc, 
Shawnee Mission KS. 
77. GAUSSIAN, e.a. M.J. Frisch, Editor. 2004, Gaussian, Inc.: Wallingford CT. 
78. Charles, L.B., Martin , K. and Montgomery. P, ed. Proteins :A Theoretical perspective of 
Dynamics, Structure and Thermodynamics. . 1988, John Wiley & Sons: USA. 
79. Weiner, S.J., et al., A new force field for molecular mechanical simulation of nucleic 
acids and proteins. Journal of the American Chemical Society, 1984. 106(3): p. 765-784. 
80. Daura, X., A.E. Mark, and W.F. Van Gunsteren, Parametrization of aliphatic CHn united 
atoms of GROMOS96 force field. 
81. Brooks, B.R., et al., CHARMM: The biomolecular simulation program. Journal of 
Computational Chemistry, 2009. 30(10): p. 1545-1614. 
82. Jorgensen, W.L. and J. Tirado-Rives, The OPLS [optimized potentials for liquid 
simulations] potential functions for proteins, energy minimizations for crystals of cyclic 
peptides and crambin. Journal of the American Chemical Society, 1988. 110(6): p. 1657-
1666. 
83. Siu, S.W., et al., Biomolecular simulations of membranes: physical properties from 
different force fields. J Chem Phys, 2008. 128(12): p. 125103. 
84. Sousa Da Silva, A.W., W.F. Vranken, and E.D. Laue, ACPYPE - AnteChamber PYthon 
Parser interfacE., in Manuscript to be submitted.: 
http://acpype.googlecode.com/svn/trunk/acpype.py. 
85. Gasteiger, E., et al., ExPASy: The proteomics server for in-depth protein knowledge and 
analysis. Nucleic Acids Res, 2003. 31(13): p. 3784-8. 
 143 
 
86. Zhou, Y., et al., Chemistry of ion coordination and hydration revealed by a K+ channel-
Fab complex at 2.0 A resolution. Nature, 2001. 414(6859): p. 43-8. 
87. Clayton, G.M., et al., Structure of the transmembrane regions of a bacterial cyclic 
nucleotide-regulated channel. Proc Natl Acad Sci U S A, 2008. 105(5): p. 1511-5. 
88. Shi, N., et al., Atomic structure of a Na+- and K+-conducting channel. Nature, 2006. 
440(7083): p. 570-4. 
89. Shafrir, Y., S.R. Durell, and H.R. Guy, Models of voltage-dependent conformational 
changes in NaChBac channels. Biophys J, 2008. 95(8): p. 3663-76. 
90. Beyl, S., et al., Probing the architecture of an L-type calcium channel with a charged 
phenylalkylamine: evidence for a widely open pore and drug trapping. The Journal of 
biological chemistry, 2007. 282(6): p. 3864-70. 
91. Lipkind, G.M. and H.A. Fozzard, Molecular modeling of interactions of dihydropyridines 
and phenylalkylamines with the inner pore of the L-type Ca2+ channel. Molecular 
pharmacology, 2003. 63(3): p. 499-511. 
92. Cheng, R.C., D.B. Tikhonov, and B.S. Zhorov, Structural model for phenylalkylamine 
binding to L-type calcium channels. The Journal of biological chemistry, 2009. 284(41): 
p. 28332-42. 
93. Lee, K.S. and R.W. Tsien, Mechanism of calcium channel blockade by verapamil, D600, 
diltiazem and nitrendipine in single dialysed heart cells. Nature, 1983. 302(5911): p. 790-
4. 
94. Shabbir, W., et al., Interaction of diltiazem with an intracellularly accessible binding site 
on Ca(V)1.2. British Journal of Pharmacology. 162(5): p. 1074-1082. 
 144 
 
95. Kudrnac, M., et al., Coupled and independent contributions of residues in IS6 and IIS6 to 
activation gating of CaV1.2. The Journal of biological chemistry, 2009. 284(18): p. 
12276-84. 
96. Suwattanasophon, C., et al., Molecular dynamics simulations on the function of the 
transmembrane Cav1.2 channel in dependence of the content of cholesterol in the 
membrane. European Biophysics Journal with Biophysics Letters. 40: p. 118-118. 
97. Bowles, D.K., et al., Hypercholesterolemia inhibits L-type calcium current in coronary 
macro-, not microcirculation. J Appl Physiol, 2004. 96(6): p. 2240-8. 
98. Hess, B., et al., GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and 
Scalable Molecular Simulation. Journal of Chemical Theory and Computation, 2008. 
4(3): p. 435-447. 
99. Chiu, S.W., et al., An improved united atom force field for simulation of mixed lipid 
bilayers. J Phys Chem B, 2009. 113(9): p. 2748-63. 
100. Clayton, G.M., et al., Structure of the transmembrane regions of a bacterial cyclic 
nucleotide-regulated channel. Proceedings of the National Academy of Sciences of the 
United States of America, 2008. 105(5): p. 1511-5. 
101. Shafrir, Y., S.R. Durell, and H.R. Guy, Models of voltage-dependent conformational 
changes in NaChBac channels. Biophysical journal, 2008. 95(8): p. 3663-76. 
102. Stary, A., et al., Molecular dynamics and mutational analysis of a channelopathy 
mutation in the IIS6 helix of Ca V 1.2. Channels (Austin), 2008. 2(3): p. 216-23. 
103. Kandt, C., W.L. Ash, and D.P. Tieleman, Setting up and running molecular dynamics 
simulations of membrane proteins. Methods, 2007. 41(4): p. 475-88. 
 145 
 
104. Nose, S., A unified formulation of the constant temperature molecular dynamics methods. 
The Journal of Chemical Physics, 1984. 81(1): p. 511-519. 
105. Parrinello, M. and A. Rahman, Polymorphic transitions in single crystals: A new 
molecular dynamics method. Journal of Applied Physics, 1981. 52(12): p. 7182-7190. 
106. Essmann, U., et al., A smooth particle mesh Ewald method. The Journal of Chemical 
Physics, 1995. 103(19): p. 8577-8593. 
107. Yang, J., et al., Molecular determinants of Ca2+ selectivity and ion permeation in L-type 
Ca2+ channels. Nature, 1993. 366(6451): p. 158-161. 
108. Dickey, A. and R. Faller, Examining the contributions of lipid shape and headgroup 
charge on bilayer behavior. Biophysical journal, 2008. 95(6): p. 2636-46. 
109. Brown, D.A. and E. London, Functions of lipid rafts in biological membranes. Annual 
review of cell and developmental biology, 1998. 14: p. 111-36. 
110. de Meyer, F. and B. Smit, Effect of cholesterol on the structure of a phospholipid bilayer. 
Proceedings of the National Academy of Sciences of the United States of America, 2009. 
106(10): p. 3654-8. 
111. Pike, L.J., The challenge of lipid rafts. Journal of lipid research, 2009. 50 Suppl: p. S323-
8. 
112. Payandeh, J., et al., The crystal structure of a voltage-gated sodium channel. Nature, 
2011. 475(7356): p. 353-8. 
113. Tikhonov, D.B. and B.S. Zhorov, Possible roles of exceptionally conserved residues 
around the selectivity filters of sodium and calcium channels. J Biol Chem, 2011. 286(4): 
p. 2998-3006. 
 
 
 146 
 
Appendix I – Parameter for molecular dynamics simulation using Gromacs 
4.0.7 
 
; VARIOUS PREPROCESSING OPTIONS 
title                      =  
cpp                      = /lib/cpp -traditional 
include                    =  
 
; RUN CONTROL PARAMETERS 
integrator                 = md 
; Start time and timestep in ps 
tinit                      = 0 
dt                         = 0.002 
nsteps                     = 5000000 
; For exact run continuation or redoing part of a run 
init_step                  = 0 
; mode for center of mass motion removal 
comm-mode                 = Linear 
; number of steps for center of mass motion removal 
nstcomm                    = 1 
 
; LANGEVIN DYNAMICS OPTIONS 
; Temperature, friction coefficient (amu/ps) and random seed 
bd-fric                    = 0 
ld-seed                   = 1993 
 
; ENERGY MINIMIZATION OPTIONS 
; Force tolerance and initial step-size 
emtol                      = 10 
emstep                     = 0.01 
; Max number of iterations in relax_shells 
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niter                      = 20 
; Step size (1/ps^2) for minimization of flexible constraints 
fcstep                     = 0 
; Frequency of steepest descents steps when doing CG 
nstcgsteep                 = 1000 
nbfgscorr                  = 10 
 
; OUTPUT CONTROL OPTIONS 
; Output frequency for coords (x), velocities (v) and forces (f) 
nstxout                    = 10000 
nstvout                    = 10000 
nstfout                    = 0 
; Checkpointing helps you continue after crashes 
nstcheckpoint              = 10000 
; Output frequency for energies to log file and energy file 
nstlog                     = 10000 
nstenergy                  = 10000 
; Output frequency and precision for xtc file 
nstxtcout                  = 10000 
xtc-precision              = 10000 
; This selects the subset of atoms for the xtc file. You can 
; Selection of energy groups 
energygrps                 = Protein MOL Ca  
 
; NEIGHBORSEARCHING PARAMETERS 
; nblist update frequency 
nstlist                    = 10 
; ns algorithm (simple or grid) 
ns-type                    = Grid 
; Periodic boundary conditions: xyz (default), no (vacuum) 
; or full (infinite systems only) 
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pbc                        = xyz 
; nblist cut-off         
rlist                      = 1 
domain-decomposition      = no 
 
; OPTIONS FOR ELECTROSTATICS AND VDW 
; Method for doing electrostatics 
coulombtype                = PME 
rcoulomb-switch           = 0 
rcoulomb                   = 1 
; Dielectric constant (DC) for cut-off or DC of reaction field 
epsilon-r                  = 1 
; Method for doing Van der Waals 
vdw-type                   = Cut-off 
; cut-off lengths        
rvdw-switch                = 0 
rvdw                       = 1 
; Apply long range dispersion corrections for Energy and Pressure 
DispCorr                   = No 
; Extension of the potential lookup tables beyond the cut-off 
table-extension            = 1 
; Spacing for the PME/PPPM FFT grid 
fourierspacing             = 0.12 
; FFT grid size, when a value is 0 fourierspacing will be used 
fourier_nx                 = 0 
fourier_ny                 = 0 
fourier_nz                 = 0 
; EWALD/PME/PPPM parameters 
pme_order                  = 4 
ewald_rtol                 = 1e-05 
ewald_geometry            = 3d 
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epsilon_surface            = 0 
optimize_fft               = no 
 
; GENERALIZED BORN ELECTROSTATICS 
; Algorithm for calculating Born radii 
gb_algorithm               = Still 
; Frequency of calculating the Born radii inside rlist 
nstgbradii                 = 1 
; Cutoff for Born radii calculation; the contribution from atoms 
; between rlist and rgbradii is updated every nstlist steps 
rgbradii                   = 2 
; Salt concentration in M for Generalized Born models 
gb_saltconc                = 0 
 
; IMPLICIT SOLVENT (for use with Generalized Born electrostatics) 
implicit_solvent           = No 
 
; OPTIONS FOR WEAK COUPLING ALGORITHMS 
; Temperature coupling   
tcoupl                     = V-rescale 
; Groups to couple separately 
tc-grps                    = Protein DOP SOL MOL Ca  Cl  
; Time constant (ps) and reference temperature (K) 
tau-t                      = 0.1 0.1 0.1 0.1 0.1 0.1   
ref-t                      = 300 300 300 300 300 300  
; Pressure coupling      
Pcoupl                     = Parrinello-Rahman 
Pcoupltype                 = semiisotropic 
; Time constant (ps), compressibility (1/bar) and reference P (bar) 
tau-p                      = 1 
compressibility           = 4.5e-5 4.5e-5 
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ref-p                      = 1.0 1.0 
; Random seed for Andersen thermostat 
andersen_seed              = 815131 
 
; SIMULATED ANNEALING   
; Type of annealing for each temperature group (no/single/periodic) 
annealing                  = no no no no no no   
 
; GENERATE VELOCITIES FOR STARTUP RUN 
gen-vel                    = no 
gen-temp                   = 300 
gen-seed                   = 173529 
 
; OPTIONS FOR BONDS     
constraints                = all-bonds 
; Type of constraint algorithm 
constraint-algorithm      = Lincs 
; Do not constrain the start configuration 
unconstrained-start        = no 
; Use successive overrelaxation to reduce the number of shake iterations 
Shake-SOR                  = no 
; Relative tolerance of shake 
shake-tol                  = 1e-04 
; Highest order in the expansion of the constraint coupling matrix 
lincs-order                = 4 
; Number of iterations in the final step of LINCS. 1 is fine for 
; normal simulations, but use 2 to conserve energy in NVE runs. 
; For energy minimization with constraints it should be 4 to 8. 
lincs-iter                 = 1 
; Lincs will write a warning to the stderr if in one step a bond 
; rotates over more degrees than 
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lincs-warnangle            = 30 
; Convert harmonic bonds to morse potentials 
morse                      = no 
 
; ENERGY GROUP EXCLUSIONS 
 
; NMR refinement stuff  
; Distance restraints type: No, Simple or Ensemble 
disre                      = No 
; Force weighting of pairs in one distance restraint: Conservative or Equal 
disre-weighting            = Conservative 
; Use sqrt of the time averaged times the instantaneous violation 
disre-mixed                = no 
disre-fc                   = 1000 
disre-tau                  = 0 
; Output frequency for pair distances to energy file 
nstdisreout                = 100 
; Orientation restraints: No or Yes 
orire                      = no 
; Orientation restraints force constant and tau for time averaging 
orire-fc                   = 0 
orire-tau                  = 0 
; Output frequency for trace(SD) to energy file 
nstorireout                = 100 
; Dihedral angle restraints: No, Simple or Ensemble 
dihre                      = No 
dihre-fc                   = 1000 
dihre-tau                 = 0 
; Output frequency for dihedral values to energy file 
nstdihreout                = 100 
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; Free energy control stuff 
free-energy                = no 
init-lambda                = 0 
delta-lambda               = 0 
sc-alpha                   = 0 
sc-sigma                   = 0.3 
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Appendix II - Multiply sequence alignment of pore domain I to II. 
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Appendix III - Multiply sequence alignment of pore domain III to IV 
 
 
 165 
 
 
 166 
 
 
 
 167 
 
 
 168 
 
 
 169 
 
 
 170 
 
 
 
 171 
 
 
 
 
 
 172 
 
 
 173 
 
Curriculum Vitae 
 
 
CHONTICHA   SUWATTANASOPHON 
chonticha.suwattanasophon@univie.ac.at 
 
 
Personal data 
Nationality: Thai 
Gender:  Female   
Date of Birth: 1 November 1979  
 
 
Education 
2007 - present UNIVERSITY OF VIENNA                                                                            Vienna, Austria 
 Ph.D Candidate , Physics 
 Interaction determinants between pore regions and voltage sensors in calcium 
channels 
 
2001-2004 MAHIDOL UNIVERSITY                                                                        Bangkok, Thailand 
 Master of Science, Physics 
 Master thesis: Molecular Dynamics of Bacillus Thuringiensis Cry4Ba Toxin 
 
1997-2001 King Mongkut’s University of Technology Thonburi          Bangkok, Thailand 
 Bachelor of Science, Physics 
 Senior project: Study the second harmonic of Nd-YAG laser 
 
 
 
 
 
 174 
 
Professional experience 
2004-2006 Pibulsongkharm Rajabhat University                                 Phitsanuloke, Thailand 
 Lecturer 
 
2001-2002 MAHIDOL UNIVERSITY                                                                  Bangkok, Thailand 
 Teacher Assistance  
 
Academic awards 
April 2010-June 2010   Short Term Grant Abroad of University of Vienna. 
                                           (Department of Chemical Engineering and Materials Science,   
                                        University of California Davis – 3 months) 
2007-2010                 Initiative Groups at University of Vienna Scholarship. 
                                         (Molecular Drug Target - Department of Pharmacology and   
                                         Toxicology, University of Vienna)   
2002-2004                The Shell Centenary Scholarship Fund 
 
Presentation 
 
 Chonticha Suwattanasophon, Roland Faller, Peter Wolschann , Anna Stary-
Weinzinger. Molecular Dynamics Simulations on the Function of the 
Transmembrane Cav1.2 Channel in Dependence of the Content of Cholesterol 
in the Membrane, 8 th European Biophysics Congress, Budapest, Hungary, 
23-27 August 2011. 
 Chonticha Suwattanasophon, Anna Stary and Peter Wolschann. Homology 
Modelling of Cav1.2 Calcium Channel, Drug Design and Discovery for 
Developing Countries, ICS-UNIDO, Trieste, Italy,  30 June-5 July2008. 
 Chonticha Suwattanasophon, Anna Stary, Peter Wolschann and Gerhard 
Buchbauer. Homology Modelling of Odorant Receptors, Österreichische 
Chemietage, Klagenfurt, Austria 2007. 
 
 175 
 
Publications 
 
 A. Stary, C. Suwattanasophon, P. Wolschann and G. Buchbauer. 2007. 
Difference in (-) citronellal binding to various odorant receptors. J. Biochem. 
Biophys. Res. Commun 4: 941-945. 
 M. Karmazinova, S. Beyl, A. Stary, C. Suwattanasophon, N. Klugbauer, S.  
Hering, L. Lacinova. 2010. Cysteines in the loop between IS5 and the pore 
helix of CaV3.1 are essential for channel gating, Pflugers Archiv-European 
Journal of Physiology 6: 1015-1028. 
 C. Suwattanasophon, R. Faller, P. Wolschann and A. Stary. Molecular 
Dynamics Simulation on the Function of the Transmembrane Cav1.2 Channel 
in Dependence of the Content of Cholesterol in the Membrane. European 
Biophysics Journal with Biophysics Letters. 40: p. 118-118. 
 
